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Pituitary-Adrenal (HPA) axis may be altered in the syndrome. This review 
collates evidence to determine the nature of HPA axis baseline activity 
and reactivity (as measured by glucocorticoid levels) differences in FXS, 
and its relationship to behaviour. Through a search electronic databases, 
15 papers were identified which provided data on humans with FXS or the 
FMR1 knockout mouse model. The findings across studies are mixed, though 
trends in the findings can be seen, including elevations in cortisol 
levels, particularly in males. Preliminary findings also highlight 
associations between cortisol levels and key behaviours associated with 
the syndrome, such as gaze avoidance. Areas for future research are 
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Abstract 
Fragile X Syndrome (FXS) is characterised by features including anxiety and autistic-like 
behaviour, which led to early hypotheses that aberrant physiological arousal may underlie the 
behavioural phenotype. In line with this, several lines of evidence suggest that the 
Hypothalamic-Pituitary-Adrenal (HPA) axis may be altered in the syndrome. This review 
collates evidence to determine the nature of HPA axis baseline activity and reactivity (as 
measured by glucocorticoid levels) differences in FXS, and its relationship to behaviour. 
Through a search electronic databases, 15 papers were identified which provided data on 
humans with FXS or the FMR1 knockout mouse model. The findings across studies are 
mixed, though trends in the findings can be seen, including elevations in cortisol levels, 
particularly in males. Preliminary findings also highlight associations between cortisol levels 
and key behaviours associated with the syndrome, such as gaze avoidance. Areas for future 
research are discussed.  
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x Preliminary findings, though mixed, suggest atypical HPA axis function in FXS 
x Cortisol levels were associated with phenotypic behaviours, such as gaze avoidance 
x Research is warranted to evaluate HPA axis function as a biomarker of autism in FXS 
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Hypothalamic-Pituitary-Adrenal Axis Function in Fragile X Syndrome and its 
Relationship to Behaviour: A Systematic Review 
Introduction 
 Fragile X Syndrome (FXS) is the most common known cause of inherited 
intellectual disability and the leading monogenetic cause of autism (Muhle, Trentacoste 
& Rapin, 2004; Turner, Webb, Wake, & Robinson, 1996), affecting approximately 1:4000 
males and 1:8000 females (Sherman, 2002). Verkerk and colleagues (1991) categorized 
the genetic locus of the disorder as being an expanded CGG repeat on the long arm of ǡ ?ǯFMR1 gene, occurring during 
maternal transmission. An expansion of 200 or more repeats typically causes the FMR1 
gene to become abnormally hypermethylated, silencing the production of the Fragile X 
Mental Retardation Protein (FMRP; Fu et al, 1991). FMRP is a ubiquitous transporter 
protein which carries target messenger ribonucleic acids (mRNAs; which contain 
genetic information) from the cell nuclei to ribosomes, where the information is 
decoded to produce specific amino acid chains for protein synthesis ((Feng et al., 1997; 
Irwin, Galvez & Greenough, 2000; Khandjian, Corbin, Woerly & Rouseau, 1996). The 
mRNAs served by FRMP have a broad range of purposes, though are largely involved in 
dendritic structure and function (Feng et al., 1997; Weiler et al., 1997). 
 The severity of the manifestation of the syndrome is variable, but individuals 
with FXS typically show marked behavioural features including deficits in attention, 
language and IQ; hyperactivity; anxiety; self-injury (particularly hand-biting); 
aggression; hyperarousal; stereotypies; and social difficulties, including gaze avoidance 
(Symons, Byiers, Raspa, Bishop & Bailey, 2010; Lachiewicz, et al., 1994; Bailey, Raspa, 
Olmsted & Holiday, 2008). The presentation of the FXS is quantitatively gender 
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dimorphic, due to the X-linked nature of the syndrome, with males typically (though not 
always) being more clearly affected than females. Crucially, anxiety plays a central role 
in many of the characteristic behaviours of the syndrome, including avoidance and 
confrontational behaviours (Sullivan, Hooper & Hatton, 2007) as well as autistic-like 
behaviour (Talisa, Boyle, Crafa & Kaufmann, 2014).  It has long been hypothesised that 
aberrant or exaggerated physiological arousal, particularly stimulus-bound, may 
underlie these traits. Due to these tendencies for individuals with the condition to 
exhibit exaggerated behavioural responses to stressors, researchers have begun to 
investigate arousal and stress-related circuits and their relevance for individuals with 
FXS. 
 The hypothalamic-ȋȌǯ
effector systems and is a circuit of interest in Fragile X research. Activation of the HPA 
axis triggers the release of glucocorticoids (such as cortisol in humans), which can be 
measured through blood or saliva sampling (Jessop & Turner-Cobb, 2008). Baseline 
release of cortisol follows a pronounced circadian rhythm marked by a peak after 
awakening, followed by a gradual decrease through the day, reaching a quiescent period 
during sleep (van Cauter, 1990): corresponding to the rest-activity cycle. Superimposed 
on this pattern, in response to physical or psychological stressors, is further pulsatile 
release of glucocorticoids, which is a normal, adaptive component of coping (Gunnar, 
1987). In the short term the physiological changes associated with this this induces are 
adaptive in that they help to provide resources for successful coping, though enduringly 
high cortisol levels may have harmful effects (McEwen, 1998). Multiple negative 
feedback loops in the HPA axis exist to maintain adaptive levels of cortisol (Herman & 
Cullinan, 1997). In addition, when stressors are chronic, the HPA system may reach a 
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stage of exhaustion (Selye, 1956) resulting in blunted cortisol levels and responses or 
even development of a pattern of decreases in response to stressors as a result of 
habituation (Miller, Chen & Zhou, 2007; Grissom & Bhatnagar, 2009).  
Individual differences in HPA activity may also be important correlates or 
modifiers of social behaviour and behavioural and psychological responding to 
stressors. For instance, it has been noted that individuǯȋ
condition characterised by chronically elevated baseline levels of cortisol) are more 
likely to experience negative psychological states, such as depression and anxiety (Kelly, 
Kelly & Faragher, 2003), suggesting that HPA hyper-activation may modify affect. In 
addition, research into shyness with participants of various ages suggests a complex 
functional interplay between cortisol and the regulation of social behaviour (for 
instance: Schmidt et al, 1997; Beaton et al, 2013; Kagan et al, 1988). Furthermore, there 
is a growing body of literature suggesting that individuals on the autism spectrum 
(which is characterised by atypical social behaviour) experience stress-related cortisol 
responses of increased magnitude and/ or duration (for instance: Spratt et al, 2012; 
Corbett, Mendoza, Abdullah, Wegellin & Levine, 2006), which may be driven by 
impaired negative feedback (Hoshino et al, 1987). Given the close association between 
FXS and autism spectrum disorder (ASD, for instance: Bailey et al, 1998), it will be 
important to consider autism symptomatology in the interpretation of FXS research.  
In light of these associations between cortisol and behaviour, it is interesting that 
researchers investigating the FMRP target mRNAs have discovered an association 
between FXS and the HPA axis. FMR1 knockout mice (an animal model of FXS) have 
been found to have fewer glucocorticoid receptors (GR-ȽȌǡ
which would decrease homeostatic feedback regarding levels of cortisol (Jafari, Seese, 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      4 
 
Babayan, Gall & Lauterborn, 2012; Miyashiro et al, 2003). Furthermore, in human 
subjects with FXS (but not typically developing or intellectually disabled controls), 
Annexin 1, a phospholipid-binding protein which mediates the inhibition by 
glucocorticoids on the HPA axis (Jessop, 1999), was synthesised and expressed 
abnormally (Sun, Cohen and Kaufmann, 2001). The level of dysregulation was closely ǯ	ǡǤ
Thus, it appears that lack of FMRP may result in excessive activation of the HPA axis, 
through impairing the negative feedback loop (Hessl et al, 2002). This highlights a 
pathway whereby cortisol regulation may be altered in FXS, which could play a direct or 
indirect relationship in the manifestation of the behavioural phenotype. Interestingly, 
broader studies of endocrine function in FXS, such as atypical negative feedback 
regulation of the thyroid (Bregman, Leckman & Rot, 1990) and cases of precocious 
puberty (Butler & Najjar, 1988; Moore, Chudley & Winter, 1990; Kowalczyk et al, 1996), 
support the presence of disturbances of the function of the hypothalamus and/or 
pituitary, which highlights another avenue to atypical cortisol regulation in the 
syndrome (Hessl, Riviera & Reiss, 2004).  
There are also further features of FXS which may have relevance for the function 
of the HPA axis, a number of which we will review. Firstly, brain changes related to FXS 
may influence the emotional evaluation of events. Activation of the stress-effector 
systems relies on the evaluation of a stimulus or event by the limbic system: the ǲǳǤǡ
amygdala, appears to be changed in FXS (Suvrathan & Chattarji, 2011). Broader 
excitatory and inhibitory imbalances in the FXS brain may also influence responding, in 
particular, a key glutamate receptor (MGluR5) which is affected in FXS plays an 
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important role in fear memory formation in the amygdala (Bear, 1998; Rodrigues et al, 
2002). In turn, functional neuroimaging (fMRI) research has highlighted resultant 
atypical fear-specific functioning of the amygdala and a possible association between 
these brain changes and socioemotional deficits in individuals with FXS (Kim et al, 
2012). These emotional-evaluative changes may clearly have downstream implications 
for cortisol release. Additionally, the gamma amino butyric acid neurotransmitter 
system appears to be commonly disordered in many neurodevelopmental disorders, 
including FXS (Braat & Kooy, 2015). Preclinically, FMRP has been shown to regulate 
GABA-ergic synaptic vesicle dynamics within the hippocampus of the Fmr1 KO mouse 
model, (Broek et al., 2016). Such genetically induced changes in the relative tonus of 
excitatory / inhibitory neurotransmitters within key limbic brain structures could 
potentially predispose to changes in stress responding. Finally, circadian rhythmicity (in 
terms of behaviour and biological clock component mRNAs in the liver) has also been 
shown to be deficient in mice lacking FMRP (Zhang et al, 2008); this broader 
disturbance of the biological clock may affect the pattern of activity in the baseline 
secretion of glucocorticoids via the HPA axis. The previous discussion highlights 
multiple ways in which HPA activity (as expressed in glucocorticoid levels) may be 
altered in FXS. In turn, activity in this system may directly modify and/or be indirectly 
associated with clinically significant behaviours in the syndrome (Hessl et al, 2002). As 
a consequence, research into the secretion of glucocorticoids has begun to emerge 
within the FXS literature. The aim of this review is to collate findings relating to HPA 
functioning in animal models of and humans with FXS. The inclusion of preclinical 
literature has been made in order to be able to conduct an in-depth analysis of the 
potential relationship between FXS and HPA function. The review addresses several 
questions:  
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a) Do individuals or animals with FXS exhibit atypical levels of glucocorticoids 
at baseline, or differences in the duration or magnitude of responses to 
stressors, compared to controls?  
b) Given the X-linked nature of the condition, are there gender differences in the 
difference aspects HPA activity, in FXS? 
c) Do measures of HPA activity relate to behaviour, in individuals with FXS? 
Method 
Selection Criteria for Studies  
Types of studies. We considered relevant empirical or observational studies, 
written in English, which assessed measures of HPA output (cortisol in humans or 
corticosterone in mice, collected via salivary or haematological methods) in humans 
with full-mutation FXS or an animal model of the human full-mutation, such as the 
FMR1 knock-out (KO) mouse. Papers were included if they contained either a group 
comparison of corticosterone levels or an analysis investigating the relationship 
between HPA activity and behaviour in individuals or animals with FXS. Case studies ǯive data or 
matched with an individual without FXS. 
Search Methods for Identification of Studies 
 Electronic search. The following databases were searched: Web of Science, 
SCOPUS, PubMed, and Academic Search Complete. The search was completed in June 
2016. 
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ȋ
database).  
 Searching other resources. Bibliographies of relevant articles were scrutinised. 
Furthermore, the titles of studies published in the following journals were searched, 
using the same terms, to ensure no papers had been missed in the database search: 
Psychoneuroendocrinology; American Journal of Medical Genetics; Journal of 
Intellectual Disability Research. These searches yielded no additional papers.   
Search Results 
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 The search is depicted in Figure 1. In total, 79 unique  papers were identified in 
the initial search, of which 17 met the inclusion criteria for this systematic review. 
 
154 Papers: 
SCOPUS (51), Web of Science (46), Academic Search Complete 
(26), PubMed (31) 
79 Unique Papers Reviewed at Title/ Abstract 
level 
23 Papers Full Text Reviewed 
17 papers 
included 
9 papers working 
with non-human 
animals 
8 papers with 
human 
participants 
6 papers rejected due to: 
No comparison group (1) 
Review mentioning cortisol but 
with no new data (4) 
No measure of cortisol (1) 
 
56 papers rejected due to: not 
having FXS participants, not 
measuring glucocorticoids or 
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a) Figure 1. Depiction of the manuscript search process  
 
Results and Discussion 
 Do Individuals or Animals with FXS Exhibit Atypical Levels of 
Glucocorticoids at Baseline, or Differences in the Duration or Magnitude of 
Responses to Stressors, Compared to Controls?  
Preclinical Literature: Results and Discussion 
Baseline HPA aActivity and circadian rhythm. in Fragile X Syndrome 
Animal Models 
Animal literature. Several studies (Table 1, includes summary of methodology 
and animal characteristics) have investigated the non-stressed corticosterone secretion 
of male KO mice compared to wild-type (WT) control animals, in order to identify 
whether changes exist in the baseline activity of the HPA axis in FXS animal models. The 
majority of studies found no genotype effect in their comparisons at single time-points, 
with male animals (Markham et al, 2006; Lauterborn, 2004; Nielsen et al, 2009; Eadie et al, 
2009; Ghilan et al, 2015). Furthermore, in a more detailed analysis, Qin and Smith (2008) 
assessed the baseline circadian rhythm of both genotypes and found no difference at 
any of the six time-points tested (Qin & Smith, 2008). However, Ttwo studies did 
identifyied genotype differences, though the nature of the difference contrasted: de 
Diego-Otero and colleagues (2009) found that KO mice had lower corticosterone levels 
at baseline than WT controls; in contrast, Qin and colleagues (2011) found a main effect 
whereby KO mice generally had higher corticosterone than WT controls. As such, there 
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is no evidence to suggest baseline HPA activity is altered in males with FXS, based on 
the preclinical evidence.  
Gender differences. No studies of this nature have utilised female animals, as such 
it is unclear whether any gender differences exist in this area (gender comparisons 
summarised in Table 4).  
Human Literature. Diurnal Rhythm.  Research investigating baseline HPA 
activity in humans has focussed upon profiling the diurnal rhythm of cortisol levels in 
this group (Table 3). Namely, Ttwo studies (Wisbeck et al, 2000; Hessl et al, 2002) 
investigated cortisol levels through routine days (without unusual or exciting events). 
Wisbeck and colleagues (2000) conducted a pilot study involving 7 females and 8 males 
(between the ages of 6-25 years) with FXS, comparing to a normative sample, Hessl and 
colleagues (2002) later built upon this with a larger study of 39 females and 70 males 
with FXS (age 6-17 years) compared to siblings without FXS (58 female, 51 male; age 6-
17 years).  In both studies, boys with FXS exhibited higher levels of cortisol, resulting 
from reduced diurnal decline, than their unaffected siblings. These findings may be 
consistent with the hypothesis, from preclinical literature on mRNA targets, of 
disordered HPA negative feedback. However, the only way to separate the direct 
influences of HPA feedback regulation and the influence of broader differences 
originating from, for instance, atypical emotional evaluation of the environment, would 
be to directly challenge the HPA axis, for instance with a dexamethasone suppression 
test (as used by Hoshino and colleagues (1987) with individuals with autism). As 
mentioned previously, heterogeneity in the preclinical literature in terms of both 
methodology and results means that it is challenging to draw conclusions about any 
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of circadian glucocorticoid release in humans with FXS. Further investigations of 
circadian rhythmicity in the HPA axis in FMR1 KO mice may help to establish further 
evidence to understand these observed differences better.  
Gender differences. Of note, there are suggestive gender-differences apparent in 
the observations. Though no differences were observed in the initial smaller study 
(Wisbeck et al, 2000), in a later study, with larger numbers of participants (Hessl et al, 
2002), visual analysis of the data revealed that the cortisol profiles of the females with 
FXS closely corresponded with those of their unaffected siblings: whereas the males 
showed more pronounced differences in cortisol levels. Of note, thoughhowever, the 
statistical significance of these differences were not evaluated (gender comparisons 
summarised in Table 4). A further discussion of gender-related differences is included 
below.  
 
HPA rReactivity to cChallenges. Early hypotheses suggested that stimulus-
bound arousal differences (Cohen, 1995) may play a significant role in the behavioural 
phenotype of FXS. Evidence to evaluate this claim has been collected across a small 
number of studies, involving both human and non-human animal participants.  in 
Fragile X Syndrome Animal Models 
Animal Literature. Exposing animals to acute stress paradigms allows for 
investigation of the magnitude and/or duration of HPA axis reactions, and whether 
these differ in the FMR1 KO model of FXS, compared to their WT counterparts. A 
commonly used trigger for acute stress with mice is to restrain the animal (for instance, 
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Magnitude of response. Seven studies were identified which had compared the 
magnitude of responses of male KO and WT mice to this procedure (implemented for 
between 15 minutes and three hours; Table 1). Three of these studies found that KO 
mice exhibited higher levels of corticosterone compared to WT controls, following the 
stressor. De Diego-Otero and colleagues (2008) observed this difference following 15 
minutes of restraint stress. In contrast, Lauterborn (2004) found a significant difference 
in corticosterone responses only after more prolonged restraint (2 hours), however 
only a trend towards a difference was observed with a shorter stressor (30 minutes). 
Ghilan and colleagues (2015) observed higher corticosterone levels after a short period 
of restraint (15 minutes) in the KO mice, compared to the WT mice. However, following 
more  significant increases in corticosterone after a short duration of restraint stress 
(15m) only in the KO mice, though after more prolonged periods of restraint (30 and 60 
minutes) both KO and WT mice showed responses which did not significantly differ in 
magnitude.  Increased stress-related elevations were also seen in response to a different 
stressor (spatial novelty) by Romero-Zerbo and colleagues (2009), who found that, 
despite initially lower baseline corticosterone levels in the KO mice, following stressors 
the KO mice exhibited higher levels of corticosterone than their WT counterparts.  
In contrast to the four studies finding elevations in KO mice responses, Eadie and 
colleagues (2009) found that KO mice had significantly lower corticosterone than WT, 
following 3 hours of restraint stress, suggesting a smaller hormonal response to the 
paradigm. Furthermore, there were no genotype differences observed in seven studies: 
three studies did not observe any genotype difference in the magnitude of 
corticosterone responses to restraint stress (Markham et al, 2006; Nielsen et al, 2009; 
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acute stress paradigms, including exposure to spatial novelty (Nielsen et al, 2009; Qin & 
Smith, 2008; Qin et al, 2011) and swim stress (Nielsen et al, 2009). Furthermore, the 
only study to use female animals (Markham et al, 2006) found no difference in peak 
responding following physical restraint for 30 minutes.  
Of interest, given the atypical social profile associated with Fragile X, de Diego-ȋ ? ? ? ?Ȍǯ
(restraint) and social stressors (housing with between 9 and 11 other animals for 15 
minutes), to investigate whether there may be differences in the nature of 
corticosterone responses. They found that , in contrast to the increased response of KO 
in response to restraint stress, KO mice showed lower levels of corticosterone following 
the social stressor than WT mice, which differs from the trend for elevations in response 
to restraint stress in other studies. This preliminarily suggests that the nature of the 
stressor (social verses physical) may be of importance when investigating stress-related 
physiology in the FXS mouse model. Finally, Aanother interesting manipulation was 
included in a study by Qin and colleagues (2011) who exposed both WT and KO animals 
to chronic restraint stress, before exposure to an acute stressor in the form of a novel 
environment (Qin et al, 2011). However, no interaction was found between the 
genotype and chronic stress, on the corticosterone responses.  
In summary, given the high numbers of null findings no firm conclusions can be 
drawn about the magnitude of responses in FXS mouse models. Where differences were 
observed, however, the trend was for male animals to exhibit higher levels of 
corticosterone. A possible reason for this variation in results between studies may be 
related to the genetic background of the mice used. Mouse strain differences have been 
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responses to stressors (Shanks, Griffiths, Zalcman, Zacharko & Anisman, 1990) and have 
been hypothesised to be associated with conflicting results more broadly, when using 
the FMR1 KO (Pietropaulo, Guilleminot, Martin, Amato & Crusio, 2011). Interestingly, 
Markham and colleagues (2006) found male KO mice had protracted responses to 30 
minutes of restraint when compared to WT mice, using mice of a C57/Bl6 background; 
however Qin and Smith (2008) did not find any genotype differences after the same 
stressor when using FVB/NJ male mice. However, clearly, there may have been other 
methodological differences between the studies which caused the differences in the 
results (see Table 1 for summary of key study methodology). For instance, the timings 
of the testing of the animals (when specified) varied between 7am and 2pm. The active 
phase of mice is typically during the night time, inverse to humans, with a peak at 
approximately 8pm (Gong et al, 2015), though of course housing and lighting conditions 
may cause this to vary. The time widows for testing across the reviewed studies 
overlapped substantially making comparisons challenging. However, this possible 
influence should be considered in future research and there is a need to establish better 
evidence on the link between sample timings, circadian rhythmicity and stress-related 
corticosterone release in FMR1 KO mice, in order to facilitate the interpretation of the 
literature.  
Duration of response. Next, several studies have investigated the duration of 
corticosterone responses. This was achieved by conducting timecourse studies 
involving sacrificing groups of mice at differing lengths of time following a restraint 
stressor. Interestingly, Markham and colleagues (2006) observed that the male KO 
animals showed a slower return to unstressed baseline than WT; a pattern which is 
consistent with the prediction of reduced HPA negative feedback. Though, two other 
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studies did not find any genotype differences between male animals in response 
duration (Nielsen et al, 2009; Qin & Smith, 2008).  
Gender differences. One study was identified which included female mice 
(Markham et al, 2006; gender comparisons summarised in Table 4). In this research, no 
difference was found in peak responding between male and female KO mice, following 
physical restraint for 30 minutes. However, female KO mice Female animals in ǯȋ ? ? ? ?Ȍshowed a different pattern of response and 
recovery to their male counterparts, but also atypical compared to the WT mice: the 
female KO mice appeared to show a protracted rise, as their the peak corticosterone 
level was at the final 60m sample, where levels would be expected to be falling (there 
were no gender differences in the WT animals). This suggests that animal gender may 
play an important role in the outcomes of research into HPA output in FXS. However, 
further research is needed.  
 
Next, several studies have investigated the duration of corticosterone responses. 
This was achieved by conducting timecourse studies involving sacrificing groups of 
mice at differing lengths of time following a restraint stressor. Interestingly, Markham 
and colleagues (2006) observed that the male KO animals showed a slower return to 
unstressed baseline than WT; a pattern which is consistent with the prediction of 
reduced HPA negative feedback. Though, two other studies did not find any genotype 
differences between male animals in response duration (Nielsen et al, 2009; Qin & ǡ ? ? ? ?ȌǤ	ǯ ȋ ? ? ? ?Ȍ
different pattern of response and recovery to their male counterparts, but also atypical: 
the female KO mice appeared to show a protracted rise, as their the peak corticosterone 
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level was at the final 60m sample, where levels would be expected to be falling (there 
were no gender differences in the WT animals). 
 Finally, there has been no research to date investigating whether individual 
differences in corticosterone responses relate to differences in behaviour. Though, it is 
unclear how such research may translate to understanding of human behaviour as the 
behavioural phenotype of the mouse model does not correspond closely to that of the 
human phenotype. Namely, in comparison to the increased levels of anxiety associated 
with FXS in humans (for instance; Cordiero et al, 2011), all studies which utilised a 
behavioural assay to assess anxiety (Elevated Plus Maze; Pellow, Chopin, File & Briley, 
1985) observed that FMR1 KO mice exhibit decreased behavioural indicators of anxiety 
relative to their WT counterparts (Qin et al, 2011; de Diego-Otero et al, 2008; Qin & 
Smith, 2008; Eadie et al, 2009). No research has been conducted to identify which 
mouse behaviours correspond to clinically significant behaviours in FXS. However, 
should these be identified, animal models may help to highlight relationships between 
HPA axis function and behaviour in FXS.  
Human Literature: Results and Discussion 
Between-Group Comparisons of Cortisol Secretion in Humans 
 Human literature. Four studies conducted between-group analyses to compare 
the release of cortisol by individuals with FXS to other groups (see Table 2 for details of 
study participant characteristics and Table 3 for details of between-group 
comparisons).  
Diurnal Rhythm. Two studies (Wisbeck et al, 2000; Hessl et al, 2002) investigated 
cortisol levels through routine days (without unusual or exciting events). In both 
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studies, boys with FXS exhibited higher levels of cortisol, resulting from reduced diurnal 
decline, than their unaffected siblings. These findings may be consistent with the 
hypothesis, from preclinical literature on mRNA targets, of disordered HPA negative 
feedback. However, the only way to separate the direct influences of HPA feedback 
regulation and the influence of broader differences originating from, for instance, 
atypical emotional evaluation of the environment, would be to directly challenge the 
HPA axis, for instance with a dexamethasone suppression test (as used by Hoshino and 
colleagues (1987) with individuals with autism). As mentioned previously, 
heterogeneity in the preclinical literature in terms of both methodology and results 
means that it is challenging to draw conclusions about any potential results between the 
findings in mice and these suggestive findings of blunting of circadian glucocorticoid 
release in humans with FXS. Further investigations of circadian rhythmicity in the HPA 
axis in FMR1 KO mice may help to establish further evidence to understand these 
observed differences better.  
Of note, there are suggestive gender-differences apparent in the observations. Though 
no differences were observed in the initial smaller study (Wisbeck et al, 2000), in a later 
study, with larger numbers of participants (Hessl et al, 2002), visual analysis of the data 
revealed that the cortisol profiles of the females with FXS closely corresponded with 
those of their unaffected siblings: whereas the males showed more pronounced 
differences in cortisol levels. Of note, though, the statistical significance of these 
differences were not evaluated. A further discussion of gender-related differences is 
included below.  
Cortisol Reactivity. Early hypotheses suggested that stimulus-bound arousal 
differences (Cohen, 1995) may be significant in FXS. Evidence to evaluate this claim has 
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been collected in Ffour studies to date, which have investigated group differences in the 
release of cortisol in response to cognitive, behavioural or physical testing (see Table 2 
for details of study participant characteristics and Table 3 for details of between-group 
comparisons). Preliminary evidence for atypical regulation is provided by a case study 
of an adult male (age 24 years) with FXS who showed an atypical pattern of adaptation 
in response to physical exercise: an early increase in cortisol followed by a large 
decrease, opposite to the pattern of adaptation seen in the healthy controls (15 males; 
Bricout et al, 2008).  
Larger studies have also evaluated differences in the magnitude of cortisol reactions, 
focussing particularly on the response to social stressors (due to the atypical social 
behaviour associated with the syndrome). The findings of these studies are mixed. 
Firstly, Hessl and colleagues (2002) observed that males with FXS (70, age 6-17 years) 
showed reduced diurnal decline in the period after meeting unfamiliar researchers, 
compared to the siblings (58 female, 51 male, age 6-17 years), which the authors 
suggested may have resulted from an increased response to this social challenge. In 
addition, Scherr and colleagues (2016) found that, in the first year of the longitudinal 
study, boys with FXS (31, age 9-14 years) showed reduced decline between a 9am and 
12pm sample (during which time an assessment battery was administered), higher 
levels of reactant cortisol following an assessment battery, when compared to TD 
controls (49, matched on non-verbal mental age, 4-9 years). These differences were not 
observed in the following two assessment years, in which fewer individuals participated 
(Scherr, 2013). Visual analysis suggested that the baseline levels of cortisol increased 
over the years of assessment in the FXS group, but not the TD group. Though theIn 
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group, though this e group difference did not reach a level of statistical significance. In 
addition, the authors noted differences in the changes of cortisol levels over the 
longitudinal assessment.  Firstly, The study authors also noted that the degree of change 
in cortisol levels over the years of the longitudinal assessment (reactant minus baseline 
levels) increased in the FXS group, as compared to the TD controls. Visual analysis 
suggested that the baseline levels of cortisol increased over the years of assessment in 
the FXS group, but not the TD group. As such, the evidence from these two studies, as 
well as the aforementioned case study, suggest possible differences in the responses of 
boys with FXS, as well as differences in the development of this regulation over time.  
However group differences were not observed in all studies. Further analysisA 
later study  of the data collected in the study by Hessl and colleagues (2002), by Hessl 
and colleagues (2006) with the same sample as the aforementioned study by the same 
team (Hessl et al, 2002)did not find any differences between the children with FXS and 
unaffected siblings in cortisol levels in response to, or following, a structured social 
challenge (Hessl et al, 2006. FXS group: 58 males, 32 females, age 6-17 years. Sibling 
group: 53 females, 37 males, age 6-17 years). Finally, Roberts and colleagues (2009) 
conducted an evaluation of 51 males with FXS (mean age 3 years) compared to 21 male 
TD controls (mean age 4 years) investigated the magnitude of cortisol responses to a 
social interaction between children with FXS and their siblings without FXS, though 
divided the FXS group according to degree of autism symptomatology in their analysis. 
It was found that, although there were no differences between young boys with FXS and 
low levels of autism symptomatology-only (who did not meet the criteria for a dual 
diagnosis of autism spectrum disorder on the CARS) and their siblings, children with 
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prior to and following social interactions with an unfamiliar experimenter (though 
there were no differences in the magnitude of the response). This suggests that there 
may be differences in cortisol profiles within the population of people with FXS, relating 
to the degree of autistic symptomatology. The relationship between cortisol and autism 
symptomatology is discussed in further detail later in this review.  
Thus, as with the findings in the preclinical literature, the findings of the studies 
in humans are heterogeneous. However, where differences were observed between the Ǯǯ	ǡ
manifested as relative increases, rather than decreases, in cortisol secretion. This 
corresponds to the preclinical observations of comparatively higher corticosterone 
responses to stressors in FMR1 KO mice in four studies; though, as mentioned above, 
seven studies found no genotype difference in these animals. However, this potential 
trend in the findings highlights an avenue for future investigation.  
 
Gender differences. Given the broad gender differences in the manifestation of 
FXS, researchers have chosen to investigate whether there are differences in cortisol 
responses between males and females with FXS, in four studies. In two studies, it was 
observed that males showed higher levels of cortisol following social challenges (a brief 
social stressor: Wisbeck et al, 2000; interaction with an unfamiliar experimenter: Hessl 
et al, 2002) than females. This suggests that atypical responding may be limited to, or at 
least exaggerated, in males with FXS, compared to females with the condition, mirroring 
the observations in the preclinical literature on the topic. Of note, however, the 
differences in both studies were based on visual observances and were not statistically 
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29 females and 31 males, age 5-20 years) found no gender differences in their studies, 
where statistical comparisons were conducted. Namely, Hessl and colleagues (2006) 
found no differences in the magnitude of response to a social challenge and Hall and 
colleagues (2008) saw no differences in diurnal decline across a day which involved 
unfamiliar social interactions in the form of evaluations by the experimenters.  
Therefore, the results between studies are mixed, which may, in part, reflect the 
higher variability in the presentation of FXS in females, resulting from processes such as 
X-inactivation. Though, in the wider literature, there is evidence of gender-related 
differences in HPA in adulthood, though it is unclear whether robust differences exist in 
younger individuals (Jessop & Turner-Cobb, 2008), such as those included in the studies 
in FXS. It is possible that there are also FXS-independent differences which contribute to 
this gender dimorphism. More detailed exploration of the relationship between other 
biomarkers (such as FMRP), cortisol and behaviour in males and females with FXS may 
help to clarify the origins of this variability and verify whether differences do exist.  
Given that individuals with FXS are prone to experiencing anxiety or phobias 
relating to many, varied situations (Cordeiro, Ballinger, Hagerman & Hessl, 2011), it is 
possible that idiosyncratic circumstances (outside of the examined social challenges or 
interactions) may trigger atypical cortisol responses. Of note, individuals with autism 
have been shown to have differential patterns of reactions to social-evaluative and non-
social (such as unpleasant sensations) stimuli (Taylor & Corbett, 2014). Individuals with 
FXS are known to experience atypical sensory processing (Belser & Sudhalter, 1995) 
and have been shown to show elevated startle responses to sensory stimuli (Miller et al, 
1999). Therefore, future research should address cortisol responses to a wider variety 
of situations which may be challenging for individuals with FXS.  
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Is there a Relationship Between Cortisol Levels and Behaviour in within Fragile X 
Syndrome? 
Animal literature. Finally, To date, there has been no research to date 
investigating whether individual differences in corticosterone responses relate to 
differences in behaviour. Though, it is unclear how such research may translate to 
understanding of human behaviour as the behavioural phenotype of the mouse model 
does not correspond closely to that of the human phenotype. Namely, in comparison to 
the increased levels of anxiety associated with FXS in humans (for instance; Cordiero et 
al, 2011), all studies which utilised a behavioural assay to assess anxiety (Elevated Plus 
Maze; Pellow, Chopin, File & Briley, 1985) observed that FMR1 KO mice exhibit 
decreased behavioural indicators of anxiety relative to their WT counterparts (Qin et al, 
2011; de Diego-Otero et al, 2008; Qin & Smith, 2008; Eadie et al, 2009). No research has 
been conducted to identify which mouse behaviours correspond to clinically significant 
behaviours in FXS. However, should these be identified, animal models may help to 
highlight relationships between HPA axis function and behaviour in FXS.   
 
 
Human literature. Five studies conducted within-group comparisons to 
investigate the relationship between salivary cortisol and measures of behaviour in 
individuals with FXS (see Table 2 for participant details and Table 54 for study details).  
Social and Autistic Behaviours. Many people with FXS display autistic-like 
characteristics including: gaze-avoidance, repetitive behaviour and shyness. However, 
not all individuals with FXS display levels of autistic symptomatology which mean that 
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they meet the diagnostic criteria for an autism spectrum disorder (Talisa et al, 2014). As 
such, a number of studies have investigated possible factors associated with the degree 
of autism symptomatology, including salivary cortisol.  
 Three studies Three studies collectedwhich have utilised observational 
measures of behaviours exhibited by individuals with FXS, during various types of social 
interaction.  and examined them in relation to salivary cortisol. Two of these studies, 
utilising the same group of participants,  observed the behaviour of individuals with FXS 
during a structured social challenges, which involved asking the child to read, answer 
questions and sing in front of others (Hall et al, 2006;; Hessl et al, 2006). Many of the 
measured behaviours were not found to have relationships with cortisol levels 
including: vocal quality (including mumbling or intrusive tones: Hessl et al, 2006) 
discomfort (participant appears in crisis, demonstrating behaviours such as self-injury, 
crying, aggression: Hessl et al, 2006. Hand-biting was also assessed separately in: Hall et 
al, 2006) non-verbal task avoidance (physically leaving the situation or covering eyes; 
Hessl et al, 2006; Hall et al, 2006), verbal refusals (Hall et al, 2006). Though, a positive 
correlation was observed with fidgeting (Hall et al 2006). Most interestingly, however, 
gaze avoidance, one of the characteristic features of the FXS phenotype, was found to 
relate to levels of cortisol in both studies, though the direction of the associations 
differed. Hessl and colleagues (2006) found that (across males and females with FXS), 
after controlling for other potential influences on cortisol levels, increased gaze 
aversion was associated with a lower post-challenge levels, to the social challenge. In 
fact, it was noted that the most gaze aversive children exhibited decreases in eye 
contact in response to the challenge. In contrast, Hall and colleagues (2006) found that 
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THowever, these findings raise two hypotheses as to whether the primary influence on 
gaze avoidance relates to autistic-like characteristics (i.e. a lack of response to social 
stimuli) or social anxiety (i.e. an excessive response to social stimuli; Hessl et al; 2006). 
Both hypotheses are interesting and warrant further investigation.  
Furthermore, the relationship between salivary cortisol and social approach 
behaviour during naturalistic social interactions has been explored in one study 
(Roberts et al, 2009). The method involved investigating social approach behaviour 
(physical approach, facial expressions and eye contact) with an experimenter when they 
were both unfamiliar (first minute of interaction) and familiar (during last hour of day-
long assessment) to the child. Typically, as also seen in the controls in this study, 
children who approach an unfamiliar person more show an increased reaction and 
those who later approach the experimenter more (when familiar) initially had higher 
baseline levels of cortisol. However, the children with FXS showed a different pattern of 
association in this study. Firstly, the participants with FXS and low -levels of autism 
symptomatology (FXS-only) showed no significant association between cortisol and 
behaviour at all. Whereas, within the group of children with FXS and high levels of 
autism symptomatology+ASD, boys with higher cortisol levels (following the 
interaction) showed fewer physical approaches to the unfamiliar experimenter: the 
opposite pattern to in the control group. As such, this study suggests a possible 
association between heightened physiological reactions to social situations, and 
increased social avoidance.  
 Further evidence on the association between cortisol and autistic behaviour in 
FXS comes from studies which have utilised broader autism screening or diagnostic 
measures. Autistic-like characteristics form a key part of the FXS behavioural phenotype 
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and, as such, have been of focus in the research on HPA associations. Hall and colleagues 
(2008) utilised a direct observational assessment measure (ADOS-G; Lord, Rutter, 
DiLavore, & Risi, 2002) with their participants. The results of the study indicated that 
lower baseline levels of cortisol were associated with higher levels of autistic behaviour. 
Hessl and colleagues (2006) also found a relationship between cortisol and some types 
of autistic behaviour: increased sensory and social relation problems were positively 
associated with cortisol reactivity to a social challenge. Roberts and colleagues (2009), 
in contrast, found that reduced cortisol reactivity (which the authors suggest could be 
related to elevated basal levels) to a social interaction was associated with increased 
autistic behaviour (as measured on a behaviour rating scale: CARS; Schopler, Reicher & 
Renner, 1980), only within the group of individuals with FXS+ASD and high levels of 
autism symptomatology; in the group of children with FXS and low levels of autism 
symptomatology-only, there was no relationship between cortisol and levels of autistic 
behaviour.  
As such, a number of studies highlight associations between HPA activity and 
this key part of the FXS behavioural phenotype. However, the nature and direction of 
this association varies, with some finding increased levels of cortisol to be associated 
with increased autism symptomatology, both other with decreased cortisol levels. The 
heterogeneity of measures behaviour (direct observation as compared to informant 
rating scales) and cortisol may underlie such differences. In addition,  
Tthe findings of Roberts and colleagues (2009) raise the possibility that levels of 
cortisol more strongly relate to behaviour in individuals with FXS and high autism 
symptomatology, as compared to those with lower symptomatology. In fact, the authors 
suggest that HPA dysregulation may serve as a biomarker of ASD in FXS. This highlights 
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interpreting the results of studies of the relationship between cortisol and behaviour in 
FXS. Though, variations in the assessment of autistic behaviour across the other 
reviewed studies make it challenging to evaluate this further based on the existing 
evidence. Future research to study the gradation of ASD in FXS would be valuable to 
delinatedelineate phenotypic boundaries and evaluate the significance of HPA function 
as a biomarker of ASD in FXS.  
There is a growing body of literature relating to idiopathic autism which is also 
of relevance to this discussion. A review of this literature, revealed differences in both 
HPA rhythm and responsiveness in individuals with autism (Taylor & Corbett, 2014). 
Typically, in response to social situations, individuals with autism exhibit blunted 
responsiveness, which corresponds to the patterns seen by both Hall and colleagues 
(2008) and Hessl and colleagues (20069). Interestingly, however, the differences 
observed in those with idiopathic autism seem to be moderated by levels of functioning: 
there is not conclusive evidence that HPA dysregulation observed in lower functioning 
individuals also applies to individuals with high functioning autism). In Roberts and ǯǡ	ASD high levels of autism 
symptomatology had lower levels of adaptive behaviour than those with FXS-onlylow 
levels of autism symptomatology (though the significance of the difference was not 
evaluated), highlighting a potential confound. Future research should examine this 
potential relationship in the FXS population.  
 A broader question relating to the question of the association between autistic 
behaviour in FXS is the debate as to whether autistic-like behaviours in individuals with 
FXS meaningfully correspond to the characteristics seen with idiopathic autism (Hall et 
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al, 2010). It is possible that autistic-like behaviours in FXS have different causal 
mechanisms and, as such, the relationships between cortisol and behaviour may differ 
in those with syndromic and non-syndromic autistic characteristics. Future research 
might help to address these issues. For instance,  Ccomparison of the relationships 
between cortisol and behaviour in those with autism, including those with non-
syndromic autism and those with FXS who meet the criteria for autism, with and 
without FXS may help to elucidate whether cortisol and behaviour relations differ in 
their nature or development, dependent upon genetic status.  
 Behaviour pProblems. Behavioural problems and challenging behaviours are a 
key issue of concern for many caregivers of people with FXS. Such behavioural issues 
are often anecdotally reported to be related to Ǯǯǡ
investigations between these behaviours and physiological responses are warranted. In 
order to explore this issue, Ttwo studies have utilised the Child Behaviour Checklist 
(CBCL; Achenbach, 1991) as a broad measure of behaviour problems, and explored 
relations between scores and with cortisol levels. Hessl and colleagues (2002; ) 
investigated the associations between cortisol and CBCL scores (controlling for other 
factors which were found to be predictive of the scores) and found that a composite 
score of cortisol significantly predicted 14% of the variance in total behaviour problem 
scores for females with FXS. Further analyses indicated that increased cortisol levels 
were specifically associated with increased social and attention problems. Furthermore, 
a composite score representing cortisol secretion on typical days significantly positively 
correlated with attention problems and approached significance for somatic complaints 
and social problems. There were no other relationships between cortisol and other of 
the measured behaviour problems, including: withdrawn behaviour, anxious or 
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depressed behaviour, thought problems, aggressive behaviour or delinquent behaviour. 
In the same study cortisol levels accounted for 8% of variance in total behaviour 
problems in the males with FXS, which approached significance. The strongest 
association with a subscale score was with withdrawn behaviour. In comparison, in a 
later study by the same teamwith the same participants (Hessl et al, 2006), no  found no 
relationship was found between CBCL scores and any cortisol measures (baseline, post-
challenge cortisol or magnitude of change) taken in relation to a social challenge. 
 Other Characteristics. Scherr and colleagues (2016) found that increased 
baseline levels of cortisol were associated with lower verbal working memory 
performance in boys with FXS, suggesting a possible link between arousal levels and 
academic-related performance.  
Synthesis and Future Research 
There are some interesting preliminary findings in this existing research. Though 
the findings are heterogeneous, there are some interesting observations and trends 
within the relatively few studies that have addressed the issue of HPA function in FXS, 
to date. In mice, no robust differences in baseline cortisol levels were seen, though there 
was some evidence of elevated stress-related reactivity. In human studies, baseline 
differences were observed in several studies (Hessl et al 2002; 2006; Roberts et al, 
2009), as well as some indications of reactivity differences, compared to TD children 
(Scherr et al, 2016; Hessl et al, 2002; Roberts et al, 2009), though such differences may 
be mediated by gender and degree of autism symptomatology. At present, specific 
conclusions about the role of cortisol levels in behaviour associated with FXS are 
difficult to draw due to the high levels of variability and lack of correspondence 
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and autistic behaviour, behaviour problems and key cognitive processes (working 
memory). Future research will undoubtedly help to clarify some of these uncertainties 
and strengthen the evidence to clarify the robustness of the observed themes.  
In addition to the suggestions discussed through the previous sections, there are several 
other considerations for future projects. The wider information on the HPA system 
highlights its complexity, with individual differences relating to multiple factors, 
including: medication, pubertal stage, gender, temperament, chronic stress, compliance 
with the sampling protocol, nature of stressors, familial genetics and BMI (Jessop & 
Turner-Cobb, 2008; Gunnar et al, 2003; Dickerson & Kemeny, 2004; Kupper et al, 2005). 
As well as the variation in study methodology, many of these potential influences have 
not been explored or accounted for in the research and may relate to the observed 
variability in study findings. Furthermore, the research to date has provided important 
but limited snapshots of the activity of the HPA axis, with the exception of Scherr and ǯǯ (2016) longitudinal study, in small groups of individuals. Prospective or ǯcteristics, 
behaviour, environment and biology would help to provide a more detailed picture of 
the role of HPA activity in this population.  
In addition, research involving humans has utilised TD comparison groups. 
However, an important step in future research will be to investigate the specificity of 
any group differences to individuals with FXS. It is possible that, rather than being 
directly FXS-related, the differences observed could relate to having an intellectual 
disability or autistic behaviour, and may be seen in others without FXS, but with similar 
characteristics. For instance, earlier research with people with autism has highlighted 
that level of cognitive functioning relates to the findings: with differences being 
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Corbett et al, 2006; Richdate & Prior, 1992; Taylor & Corbett, 2014). In addition, given 
the aforementioned potential link also between levels of autism symptomatology 
autism and cortisol levels in those without FXS, and the high levels of autistic behaviour 
seen in people with FXS (Clifford et al, 2007), this clearly may be a confound in the 
differences seen. This is particularly pertinent given the findings of Roberts and 
colleagues (2009), who found that cortisol differences in FXS, compared to TD controls, 
was dependent upon levels of autism symptomatology autism status. Thus, future 
research should employ control groups to help address these potential confounds, 
including those with non-syndromic autism and those with idiopathic intellectual 
disabilities.  
In addition, in the human literature discussed above, much of the focus has been 
upon investigating HPA responses relating to social interactions or demands, in 
individuals with FXS. Given that individuals with FXS are prone to experiencing 
exaggerated behavioural responses, anxiety or phobias relating to many, varied 
situations (Cordeiro, Ballinger, Hagerman & Hessl, 2011), it is possible that 
idiosyncratic circumstances (outside of the examined social challenges or interactions) 
may also trigger atypical cortisol responses that differ in magnitude or duration, 
compared to the general population. For instance, individuals with FXS are known to 
experience atypical sensory processing (Belser & Sudhalter, 1995) and have been 
shown to show elevated startle responses to sensory stimuli (Miller et al, 1999). Of note, 
research with individuals with autism has highlighted have been shown to have 
differential patterns of reactions to social-evaluative and non-social (such as unpleasant 
sensations) stimuli (Taylor & Corbett, 2014). Individuals with FXS are known to 
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experience atypical sensory processing (Belser & Sudhalter, 1995) and have been 
shown to show elevated startle responses to sensory stimuli (Miller et al, 1999). 
Therefore, future research should address cortisol responses to a wider variety of 
situations which may be challenging for individuals with FXS, in order to gain a broader 
picture of HPA activity in this populationǡǯ-to-day 
challenges. .   
 
Finally, given the possible significance of arousal differences, as evidenced by 
potential links with cognition and behaviour, researchers should also evaluate potential 
strategies for managing levels of arousal and systematically assess for any resultant 
improvements more widely. Scherr and colleagues (2016) highlight that individuals 
with FXS may benefit from targeted arousal-reducing interventions, such as the 
teaching of coping skills or relaxation techniques. This could include, for instance, the 
use of mindfulness-based techniques, which have been shown to reduce levels of 
arousal in individuals with Williams Syndrome (Miodrag et al., 2013Miodrag et al., 2013).  
There has been a paucity of systematic evaluations of potential interventions for arousal 
issues in individuals with FXS, which include physiological measures, such as 
assessment of cortisol. However, Hall and colleagues (Hall, Lightbody, McCarthy, Parker, 
& Reiss, 2012) piloted intranasal oxytocin as an intervention for social anxiety in a small 
group of boys with FXS and found both increases in eye contact and decreases in 
cortisol levels after administration. This suggests that there may be avenues for both 
pharmacotherapy and behavioural interventions when seeking ways to support 
individuals with FXS in this area.  
Conclusion  
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In summary, there is emerging evidence that cortisol levels differ in individuals 
with FXS compared to TD controls and relate to socially significant behaviours, thus 
highlighting a number of important avenues for future exploration. Delineating the 
significance and role of HPA activity in the syndrome will help to further our 
understanding of the mechanisms of the condition and may lead to provision of more 
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Participant characteristics in studies investigating cortisol secretion in humans with Fragile X Syndrome 
Study FXS participants Control Participants 
N (M/F) Age Number with 
Autism 
N (M/F) Age Characteristics 
Bricout et al (2008) 1 M 24y N/A 15 (M)  - ǲǳ 











Friedman, & Reiss 
(2006) 
32 (F) 58 (M)* 
  
6-17y (Mean 10.89) 
 







of FXS or pre-
mutation using 
southern blot.) 
Hall, DeBernadis & 
Reiss (2006) 
40 (F) 74 (M)* 6-17y (male 
mean:11.06y, female 
mean 10.42y) 
N/A - - - 
Hall, Lightbody & 
Reiss (2008) 
29 (F) 31 (M) 5-20y (M mean: 13.21, F 
mean, 13.06) 
16 M and 6 F 
autism (23 M 
and 13 F 
autism 
spectrum) 
- - - 
Roberts et al (2009) 51 (M)  FXS-only- mean 3.99y; 
FXS+ASD+ mean 3.55y 
18 with 
autism 
21 (M) Mean: 4.05y Gender-matched 
typically developing 









© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      52 
 
 status.  
Scherr, Hahn, Hooper, 
Hatton & Roberts 
(2016) 
31 (M)** 9.67-14.58y (Mean 12.4, 
SD 1.29) 
N/A 49 (M)** 4.92-9.5y 
(Mean 7.0y, 
SD 1.04y) 
TD, matched on non-
verbal mental age at 
beginning of 
longitudinal study. 
Wisbeck et al (2000) 
 
7 (F) 8(M) 
 
6-25y (M mean 13.5y, F 
mean 13.9y) 
 




Data analysed in 
same laboratory. 
ns= non-significant. m=minutes. y=years M=male, F=female  
*Note: same group of participants in three studies. group of participants as Hessl and colleagues (2002)  
**Sub-set of total study participants for whom cortisol data was available. 
+ Fragile X Syndrome and high levels of autism symptomatology (as indicated by a score on the Child Autism Rating Scale (CARS; 
Schopler, Reicher & Renner, 1988) above the cut-off for an autism spectrum disorder) 
-Fragile X Syndrome and low levels of autism symptomatology (as indicated by a score below the cut-off for an autism spectrum 
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Comparisons of cortisol levels between groups of individuals with Fragile X Syndrome or comparison groups 
 Study Stressor Cortisol test  Cortisol Findings  
   Method Sample Timings Within group (FXS) 
Between groups (control comparison)Group 
comparisons 
Bricout et al (2008) Sub-maximal incremental 












FXS cortisol elevated during the first 20 minutes 
of the test (start inclusive) compared to controls 
and showed a decrease at exercise+40m, 
opposite to controls who showed an increase 
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Hessl et al (2002) - Saliva (Salivette roll 
soaked 1-2 m). No 
citrus <30m, no dairy 
<60m 
 
Evaluation day. 30m 
after waking, during 
testing (11am), prior to 
social challenge 
(3.30pm), 30m after 
social challenge, 90m 
after social challenge, 
bedtime. Cortisol levels 
for each sample were 
standardised by z-score 
transformation and 
averaged across the 
evaluation day to create 
composite score. 
2 consecutive typical 
non-school days. Within 
30m waking, before 
breakfast, one hour 
before lunch, one hour 
prior to dinner, bedtime. 
Cortisol levels for each 
sample were 
standardised by z-score 
transformation and 
averaged across the 
typical days to create 
composite score. 
-Typical Day. Males and females both exhibited a 
normal diurnal decline. Males showed slower 
decline (higher cortisol) post-lunch until 
bedtime than females.  
Experimental Day. Males had greater response to 
visit: less decline (higher levels) between pre-
breakfast and pre-lunch. Possibly related to 
meeting novel experimenter.  
Typical Day. Male FXS cortisol elevated 
compared to siblings on typical days (as 
indicated by reduced diurnal decline) but not 
females.  
Experimental day. Females did not differ from 
siblings. Males showed higher levels between 
pre-breakfast and pre-lunch samples.  
 
Hessl, Glaser, Dyer-
Friedman, & Reiss (2006) 
Social Challenge (in home) 
modified from protocol 
used by Herbert, Bellack 
and Hope (1991). 
Saliva (Salivette cotton 
roll soaked 1-2 m). No 
citrus <30m, no dairy 
<60m 
2 samples: prior to 
social challenge (~3pm) 
and 30m after beginning 
social challenge 
No gender differences in FXS participants.  
FXS showed higher pre-challenge levels than 
siblings. No differences in degree of change or 
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Counterbalanced 
presentation of one 15-
20m session of including 
the following conditions: 
child interview, silent 
reading, oral reading, 
singing.  
  increased cortisol through whole home 
assessment period (reported in Hessl et al 2002) 
Hall, DeBernadis & Reiss 
(2006) 
Social Challenge. 
Conducted in-home at 
approximately 3pm. Fixed 
order presentation of one 
15-20m session of each of 
the following conditions: 
child interview, silent 
reading, oral reading, 
singing. 
Saliva (Salivette cotton 







Hall, Lightbody & Reiss 
(2008) 
In home assessment 
including intelligence and 
autism testing.  
Saliva (Salivette cotton 






dinner (5pm), and pre-
bedtime (9pm).  
-No main effect of gender 
- 
Roberts et al (2009) Naturalistic interactions 
with experimenter 
Saliva (Salivette cotton 
roll soaked 1-2 m). No 




assessment.Time of day 
not specified. 
FXS+ASD higher baseline and post-assessment 
than FXS-only. No group difference in magnitude 
of response.  
FXS+ASD higher post assessment and baseline 
than TD. No differences FXS-only and TD. No 
differences in magnitude of response. 
FXS+ASD higher post assessment and baseline 
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differences in magnitude of response.  
Scherr et al (2016) Neurocognitive assessment 
battery 
Saliva (Salivette, 1-2 m) Baseline 15m (pre-
assessment: 9am) and 
conclusion of 
assessment (12pm). 
Taken in Year 1, 2 and 3 
of longitudinal 
assessment 
Visual trend for increase in baseline cortisol over 
time (each year of longitudinal study). Not seen 
in TD. 
Both groups showed lower reactant cortisol than 
baseline. Year 1: FXS had significantly higher 
reactant than TD. Not significant at other time 
points. Non-significant trend for FXS to show 
greater change in time of cortisol (reactant-
baseline) than TD. Both groups showed lower 
reactant cortisol than baseline. Year 1: FXS had 
significantly higher reactant than TD. Not 
significant at other time points. Non-significant 
trend for FXS to show greater change in time of 
cortisol (reactant-baseline) than TD.  






Social Challenge modified 
from Herbert and ǯ
(1991). Two 2-minute 
interpersonal role-play 
tasks: speech/song and 
reading aloud.  
 Saliva (Salivette cotton 
roll soaked 1-2 m). No 
citrus <30m or dairy 
<60m 
 
Day 1: evaluation day. 
Pre-breakfast, 30m post-
stress, 90m post-stress, 
pre-dinner, bedtime.  
Days 2&3: routine days. 
Pre-breakfast, pre-lunch, 
pre-dinner (no data for 
normative sample), 
bedtime. Average taken 
at each time-point 
across 2 days. 
Routine Days. Compared to normative, FXS 
higher at lunch and bedtime (no pre-dinner 
sample to compare)Routine Days. No male and 
female difference.  
 
Experimental Day. Males significantly higher 
than females 30m post-stressor and before 
bedtime.  
Routine Days. Compared to normative, FXS 
higher at lunch and bedtime (no pre-dinner 
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Gender comparisons of cortisol levels in individuals with Fragile X Syndrome 
 Study Participant Type N Aspect of HPA activity 
measured 
Gender comparison findings 
Hessl et al (2002) Human 39 (F), 70 (M)   Typical day circadian rhythm 
(average 2 days) 
Males and females both 
exhibited a normal diurnal 
decline. Males showed 
slower decline (higher 
cortisol) post-lunch until 
bedtime than females.  
   Experimental day circadian 
rhythm (involves novelty 
and social challenges) 
Males had greater response 
to visit than females: less 
decline (higher levels) 
between pre-breakfast and 
pre-lunch. Possibly related to 
meeting novel experimenter. 
Hessl, Glaser, Dyer-Friedman, & 
Reiss (2006) 
Human 32 (F) 58 (M)* 
 
Reaction to social challenge 
(pre and post measures) 
No gender differences in FXS 
participants.  
Hall, Lightbody & Reiss (2008) Human 29 (F) 31 (M) Collection at four time points 
during evaluation day 
No main effect of gender 
Wisbeck et al (2000) 
 
 
Human 7 (F) 8(M) 
 
Typical day Circadean 
rhythm (average 2 days) 
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   Experimental day circadian 
rhythm (involves novelty 
and social challenges) 
Males significantly higher 
than females 30m post-
stressor and before bedtime. 
Markham et al (2006) Mouse 8-12 per group Response to acute stressor 
(restraint) 
Different patterns of 
response and recovery to 
30m of restraint stress. 
Males show protracted 
return to unstressed 
baseline; females show 
protracted rise. Peak 
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Studies assessing associations between cortisol and behaviour in individuals with Fragile X Syndrome 
Study Behavioural measure Association of behaviour with cortisol?  
Topic Method Typical Day Experimental Day Other 
Pre-challenge Reactivity Post-challenge 





















- - - Males. Composite 
cortisol level 
(unspecified) 
accounted for 8% of 












levels account for 
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social and attention 
problems.  

























both males and 










Aman et al, 
1985); CBCL and 
Autism Behaviour 
Checklist (Krug, 
Arick, & Almond, 
1993) 






in FXS (no other 
associations). No 
associations in 
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- - - 
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Bodfish et al, 
1995) 
- No association 
between cortisol 
and prevalence or 
number of forms 
of SIB. 
- - - 





















No associations - 






Roberts et al, 
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contact) 
- No associations in 





and eye contact 
during familiar 
social approach.  
No association in 
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memory test, for 
both groups.  
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Hypothalamic-Pituitary-Adrenal Axis Function in Fragile X Syndrome and its 
Relationship to Behaviour: A Systematic Review 
Introduction 
 Fragile X Syndrome (FXS) is the most common known cause of inherited 
intellectual disability and the leading monogenetic cause of autism (Muhle, Trentacoste 
& Rapin, 2004; Turner, Webb, Wake, & Robinson, 1996), affecting approximately 1:4000 
males and 1:8000 females (Sherman, 2002). Verkerk and colleagues (1991) categorized 
the genetic locus of the disorder as being an expanded CGG repeat on the long arm of ǡ ?ǯFMR1 gene, occurring during 
maternal transmission. An expansion of 200 or more repeats typically causes the FMR1 
gene to become abnormally hypermethylated, silencing the production of the Fragile X 
Mental Retardation Protein (FMRP; Fu et al, 1991). FMRP is a ubiquitous transporter 
protein which carries target messenger ribonucleic acids (mRNAs; which contain 
genetic information) from the cell nuclei to ribosomes, where the information is 
decoded to produce specific amino acid chains for protein synthesis ((Feng et al., 1997; 
Irwin, Galvez & Greenough, 2000; Khandjian, Corbin, Woerly & Rouseau, 1996). The 
mRNAs served by FRMP have a broad range of purposes, though are largely involved in 
dendritic structure and function (Feng et al., 1997; Weiler et al., 1997). 
 The severity of the manifestation of the syndrome is variable, but individuals 
with FXS typically show marked behavioural features including deficits in attention, 
language and IQ; hyperactivity; anxiety; self-injury (particularly hand-biting); 
aggression; hyperarousal; stereotypies; and social difficulties, including gaze avoidance 
(Symons, Byiers, Raspa, Bishop & Bailey, 2010; Lachiewicz, et al., 1994; Bailey, Raspa, 
Olmsted & Holiday, 2008). The presentation of the FXS is quantitatively gender 
*Manuscript without Tracked Changes
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dimorphic, due to the X-linked nature of the syndrome, with males typically (though not 
always) being more clearly affected than females. Crucially, anxiety plays a central role 
in many of the characteristic behaviours of the syndrome, including avoidance and 
confrontational behaviours (Sullivan, Hooper & Hatton, 2007) as well as autistic-like 
behaviour (Talisa, Boyle, Crafa & Kaufmann, 2014).  It has long been hypothesised that 
aberrant or exaggerated physiological arousal, particularly stimulus-bound, may 
underlie these traits. Due to these tendencies for individuals with the condition to 
exhibit exaggerated behavioural responses to stressors, researchers have begun to 
investigate arousal and stress-related circuits and their relevance for individuals with 
FXS. 
 The hypothalamic-pituitary adrenal (HPA) axis is one oǯ
effector systems and is a circuit of interest in Fragile X research. Activation of the HPA 
axis triggers the release of glucocorticoids (such as cortisol in humans), which can be 
measured through blood or saliva sampling (Jessop & Turner-Cobb, 2008). Baseline 
release of cortisol follows a pronounced circadian rhythm marked by a peak after 
awakening, followed by a gradual decrease through the day, reaching a quiescent period 
during sleep (van Cauter, 1990): corresponding to the rest-activity cycle. Superimposed 
on this pattern, in response to physical or psychological stressors, is further pulsatile 
release of glucocorticoids, which is a normal, adaptive component of coping (Gunnar, 
1987). In the short term the physiological changes associated with this are adaptive in 
that they help to provide resources for successful coping, though enduringly high 
cortisol levels may have harmful effects (McEwen, 1998). Multiple negative feedback 
loops in the HPA axis exist to maintain adaptive levels of cortisol (Herman & Cullinan, 
1997). In addition, when stressors are chronic, the HPA system may reach a stage of 
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exhaustion (Selye, 1956) resulting in blunted cortisol levels and responses or even 
development of a pattern of decreases in response to stressors as a result of habituation 
(Miller, Chen & Zhou, 2007; Grissom & Bhatnagar, 2009).  
Individual differences in HPA activity may also be important correlates or 
modifiers of social behaviour and behavioural and psychological responding to 
stressors. For instance, it has been noted that individuals with ǯ (a 
condition characterised by chronically elevated baseline levels of cortisol) are more 
likely to experience negative psychological states, such as depression and anxiety (Kelly, 
Kelly & Faragher, 2003), suggesting that HPA hyper-activation may modify affect. In 
addition, research into shyness with participants of various ages suggests a complex 
functional interplay between cortisol and the regulation of social behaviour (for 
instance: Schmidt et al, 1997; Beaton et al, 2013; Kagan et al, 1988). Furthermore, there 
is a growing body of literature suggesting that individuals on the autism spectrum 
(which is characterised by atypical social behaviour) experience stress-related cortisol 
responses of increased magnitude and/ or duration (for instance: Spratt et al, 2012; 
Corbett, Mendoza, Abdullah, Wegellin & Levine, 2006), which may be driven by 
impaired negative feedback (Hoshino et al, 1987). Given the close association between 
FXS and autism spectrum disorder (ASD, for instance: Bailey et al, 1998), it will be 
important to consider autism symptomatology in the interpretation of FXS research.  
In light of these associations between cortisol and behaviour, it is interesting that 
researchers investigating the FMRP target mRNAs have discovered an association 
between FXS and the HPA axis. FMR1 knockout mice (an animal model of FXS) have 
been found to have fewer glucocorticoid receptors (GR-ȽȌal dendrites, 
which would decrease homeostatic feedback regarding levels of cortisol (Jafari, Seese, 
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Babayan, Gall & Lauterborn, 2012; Miyashiro et al, 2003). Furthermore, in human 
subjects with FXS (but not typically developing or intellectually disabled controls), 
Annexin 1, a phospholipid-binding protein which mediates the inhibition by 
glucocorticoids on the HPA axis (Jessop, 1999), was synthesised and expressed 
abnormally (Sun, Cohen and Kaufmann, 2001). The level of dysregulation was closely 
associated with ǯFMRP, suggesting a direct regulatory relationship. 
Thus, it appears that lack of FMRP may result in excessive activation of the HPA axis, 
through impairing the negative feedback loop (Hessl et al, 2002). This highlights a 
pathway whereby cortisol regulation may be altered in FXS, which could play a direct or 
indirect relationship in the manifestation of the behavioural phenotype. Interestingly, 
broader studies of endocrine function in FXS, such as atypical negative feedback 
regulation of the thyroid (Bregman, Leckman & Rot, 1990) and cases of precocious 
puberty (Butler & Najjar, 1988; Moore, Chudley & Winter, 1990; Kowalczyk et al, 1996), 
support the presence of disturbances of the function of the hypothalamus and/or 
pituitary, which highlights another avenue to atypical cortisol regulation in the 
syndrome (Hessl, Riviera & Reiss, 2004).  
There are also further features of FXS which may have relevance for the function 
of the HPA axis, a number of which we will review. Firstly, brain changes related to FXS 
may influence the emotional evaluation of events. Activation of the stress-effector 
systems relies on the evaluation of a stimulus or event by the limbic system: the ǲǳǤǡ
amygdala, appears to be changed in FXS (Suvrathan & Chattarji, 2011). Broader 
excitatory and inhibitory imbalances in the FXS brain may also influence responding, in 
particular, a key glutamate receptor (MGluR5) which is affected in FXS plays an 
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important role in fear memory formation in the amygdala (Bear, 1998; Rodrigues et al, 
2002). In turn, functional neuroimaging (fMRI) research has highlighted resultant 
atypical fear-specific functioning of the amygdala and a possible association between 
these brain changes and socioemotional deficits in individuals with FXS (Kim et al, 
2012). These emotional-evaluative changes may clearly have downstream implications 
for cortisol release. Additionally, the gamma amino butyric acid neurotransmitter 
system appears to be commonly disordered in many neurodevelopmental disorders, 
including FXS (Braat & Kooy, 2015). Preclinically, FMRP has been shown to regulate 
GABA-ergic synaptic vesicle dynamics within the hippocampus of the Fmr1 KO mouse 
model, (Broek et al., 2016). Such genetically induced changes in the relative tonus of 
excitatory / inhibitory neurotransmitters within key limbic brain structures could 
potentially predispose to changes in stress responding. Finally, circadian rhythmicity (in 
terms of behaviour and biological clock component mRNAs in the liver) has also been 
shown to be deficient in mice lacking FMRP (Zhang et al, 2008); this broader 
disturbance of the biological clock may affect the pattern of activity in the baseline 
secretion of glucocorticoids via the HPA axis. The previous discussion highlights 
multiple ways in which HPA activity (as expressed in glucocorticoid levels) may be 
altered in FXS. In turn, activity in this system may directly modify and/or be indirectly 
associated with clinically significant behaviours in the syndrome (Hessl et al, 2002). As 
a consequence, research into the secretion of glucocorticoids has begun to emerge 
within the FXS literature. The aim of this review is to collate findings relating to HPA 
functioning in animal models of and humans with FXS. The inclusion of preclinical 
literature has been made in order to be able to conduct an in-depth analysis of the 
potential relationship between FXS and HPA function. The review addresses several 
questions:  
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a) Do individuals or animals with FXS exhibit atypical levels of glucocorticoids 
at baseline, or differences in the duration or magnitude of responses to 
stressors, compared to controls?  
b) Given the X-linked nature of the condition, are there gender differences in the 
difference aspects HPA activity, in FXS? 
c) Do measures of HPA activity relate to behaviour, in individuals with FXS? 
Method 
Selection Criteria for Studies  
Types of studies. We considered relevant empirical or observational studies, 
written in English, which assessed measures of HPA output (cortisol in humans or 
corticosterone in mice, collected via salivary or haematological methods) in humans 
with full-mutation FXS or an animal model of the human full-mutation, such as the 
FMR1 knock-out (KO) mouse. Papers were included if they contained either a group 
comparison of corticosterone levels or an analysis investigating the relationship 
between HPA activity and behaviour in individuals or animals with FXS. Case studies ǯresults were compared to normative data or 
matched with an individual without FXS. 
Search Methods for Identification of Studies 
 Electronic search. The following databases were searched: Web of Science, 
SCOPUS, PubMed, and Academic Search Complete. The search was completed in June 
2016. 
 Search terms. ǣȋȋǲǳ
OR FMR1ȌȋȗȌȌǤǮǯǡ
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      7 
 ǮǯǮǯȋable option within the 
database).  
 Searching other resources. Bibliographies of relevant articles were scrutinised. 
Furthermore, the titles of studies published in the following journals were searched, 
using the same terms, to ensure no papers had been missed in the database search: 
Psychoneuroendocrinology; American Journal of Medical Genetics; Journal of 
Intellectual Disability Research. These searches yielded no additional papers.   
Search Results 
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 The search is depicted in Figure 1. In total, 79 unique papers were identified in 
the initial search, of which 17 met the inclusion criteria for this systematic review. 
 
154 Papers: 
SCOPUS (51), Web of Science (46), Academic Search Complete 
(26), PubMed (31) 
79 Unique Papers Reviewed at Title/ Abstract 
level 
23 Papers Full Text Reviewed 
17 papers 
included 
9 papers working 
with non-human 
animals 
8 papers with 
human 
participants 
6 papers rejected due to: 
No comparison group (1) 
Review mentioning cortisol but 
with no new data (4) 
No measure of cortisol (1) 
 
56 papers rejected due to: not 
having FXS participants, not 
measuring glucocorticoids or 
not being in English 
Remove 75 
duplicates 
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Figure 1. Depiction of the manuscript search process  
Results and Discussion 
Do Individuals or Animals with FXS Exhibit Atypical Levels of Glucocorticoids at 
Baseline, or Differences in the Duration or Magnitude of Responses to Stressors, 
Compared to Controls?  
Baseline HPA activity and circadian rhythm.  
Animal literature. Several studies (Table 1, includes summary of methodology 
and animal characteristics) have investigated the non-stressed corticosterone secretion 
of male KO mice compared to wild-type (WT) control animals, in order to identify 
whether changes exist in the baseline activity of the HPA axis in FXS animal models. The 
majority of studies found no genotype effect in their comparisons at single time-points, 
with male animals (Markham et al, 2006; Lauterborn, 2004; Nielsen et al, 2009; Eadie et al, 
2009; Ghilan et al, 2015). Furthermore, in a more detailed analysis, Qin and Smith (2008) 
assessed the baseline circadian rhythm of both genotypes and found no difference at 
any of the six time-points tested (Qin & Smith, 2008). However, two studies did identify 
genotype differences, though the nature of the difference contrasted: de Diego-Otero 
and colleagues (2009) found that KO mice had lower corticosterone levels at baseline 
than WT controls; in contrast, Qin and colleagues (2011) found a main effect whereby 
KO mice generally had higher corticosterone than WT controls. As such, there is no 
evidence to suggest baseline HPA activity is altered in males with FXS, based on the 
preclinical evidence.  
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Gender differences. No studies of this nature have utilised female animals, as such 
it is unclear whether any gender differences exist in this area (gender comparisons 
summarised in Table 4).  
Human Literature.  Research investigating baseline HPA activity in humans has 
focussed upon profiling the diurnal rhythm of cortisol levels in this group (Table 3). 
Namely, two studies investigated cortisol levels through routine days (without unusual 
or exciting events). Wisbeck and colleagues (2000) conducted a pilot study involving 7 
females and 8 males (between the ages of 6-25 years) with FXS, comparing to a 
normative sample, Hessl and colleagues (2002) later built upon this with a larger study 
of 39 females and 70 males with FXS (age 6-17 years) compared to siblings without FXS 
(58 female, 51 male; age 6-17 years).  In both studies, boys with FXS exhibited higher 
levels of cortisol, resulting from reduced diurnal decline, than their unaffected siblings. 
These findings may be consistent with the hypothesis, from preclinical literature on 
mRNA targets, of disordered HPA negative feedback. However, the only way to separate 
the direct influences of HPA feedback regulation and the influence of broader 
differences originating from, for instance, atypical emotional evaluation of the 
environment, would be to directly challenge the HPA axis, for instance with a 
dexamethasone suppression test (as used by Hoshino and colleagues (1987) with 
individuals with autism). As mentioned previously, heterogeneity in the preclinical 
literature in terms of both methodology and results means that it is challenging to draw 
conclusions about any potential results between the findings in mice and these 
suggestive findings of blunting of circadian glucocorticoid release in humans with FXS. 
Further investigations of circadian rhythmicity in the HPA axis in FMR1 KO mice may 
help to establish further evidence to understand these observed differences better.  
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Gender differences. Of note, there are suggestive gender-differences apparent in 
the observations. Though no differences were observed in the initial smaller study 
(Wisbeck et al, 2000), in a later study, with larger numbers of participants (Hessl et al, 
2002), visual analysis of the data revealed that the cortisol profiles of the females with 
FXS closely corresponded with those of their unaffected siblings: whereas the males 
showed more pronounced differences in cortisol levels. Of note, however, the statistical 
significance of these differences were not evaluated (gender comparisons summarised 
in Table 4).  
HPA reactivity to challenges. Early hypotheses suggested that stimulus-bound 
arousal differences (Cohen, 1995) may play a significant role in the behavioural 
phenotype of FXS. Evidence to evaluate this claim has been collected across a small 
number of studies, involving both human and non-human animal participants.  
Animal Literature. Exposing animals to acute stress paradigms allows for 
investigation of the magnitude and/or duration of HPA axis reactions, and whether 
these differ in the FMR1 KO model of FXS, compared to their WT counterparts. A 
commonly used trigger for acute stress with mice is to restrain the animal (for instance, 
in a small tube) for a period of time. A summary of this research is included in Table 1.  
Magnitude of response. Seven studies were identified which had compared the 
magnitude of responses of male KO and WT mice to this procedure (implemented for 
between 15 minutes and three hours; Table 1). Three of these studies found that KO 
mice exhibited higher levels of corticosterone compared to WT controls, following the 
stressor. De Diego-Otero and colleagues (2008) observed this difference following 15 
minutes of restraint stress. In contrast, Lauterborn (2004) found a significant difference 
in corticosterone responses only after more prolonged restraint (2 hours), however 
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only a trend towards a difference was observed with a shorter stressor (30 minutes). 
Ghilan and colleagues (2015) observed higher corticosterone levels after a short period 
of restraint (15 minutes) in the KO mice, compared to the WT mice. However, following 
more prolonged periods of restraint (30 and 60 minutes) both KO and WT mice showed 
responses which did not significantly differ in magnitude.  Increased stress-related 
elevations were also seen in response to a different stressor (spatial novelty) by 
Romero-Zerbo and colleagues (2009), who found that, despite initially lower baseline 
corticosterone levels in the KO mice, following stressors the KO mice exhibited higher 
levels of corticosterone than their WT counterparts.  
In contrast to the four studies finding elevations in KO mice responses, Eadie and 
colleagues (2009) found that KO mice had significantly lower corticosterone than WT, 
following 3 hours of restraint stress, suggesting a smaller hormonal response to the 
paradigm. Furthermore, there were no genotype differences observed in seven studies: 
three studies did not observe any genotype difference in the magnitude of 
corticosterone responses to restraint stress (Markham et al, 2006; Nielsen et al, 2009; 
Qin & Smith, 2008) and a further four studies also observed no difference using other 
acute stress paradigms, including exposure to spatial novelty (Nielsen et al, 2009; Qin & 
Smith, 2008; Qin et al, 2011) and swim stress (Nielsen et al, 2009).  
Of interest, given the atypical social profile associated with Fragile X, de Diego-ȋ ? ? ? ?Ȍǯ
(restraint) and social stressors (housing with between 9 and 11 other animals for 15 
minutes), to investigate whether there may be differences in the nature of 
corticosterone responses. They found that KO mice showed lower levels of 
corticosterone following the social stressor than WT mice, which differs from the trend 
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for elevations in response to restraint stress in other studies. This preliminarily 
suggests that the nature of the stressor (social verses physical) may be of importance 
when investigating stress-related physiology in the FXS mouse model. Finally, another 
interesting manipulation was included in a study by Qin and colleagues (2011) who 
exposed both WT and KO animals to chronic restraint stress, before exposure to an 
acute stressor in the form of a novel environment (Qin et al, 2011). However, no 
interaction was found between the genotype and chronic stress, on the corticosterone 
responses.  
In summary, given the high numbers of null findings no firm conclusions can be 
drawn about the magnitude of responses in FXS mouse models. Where differences were 
observed, however, the trend was for male animals to exhibit higher levels of 
corticosterone. A possible reason for this variation in results between studies may be 
related to the genetic background of the mice used. Mouse strain differences have been 
previously found to influence both the magnitude and duration of corticosterone 
responses to stressors (Shanks, Griffiths, Zalcman, Zacharko & Anisman, 1990) and have 
been hypothesised to be associated with conflicting results more broadly, when using 
the FMR1 KO (Pietropaulo, Guilleminot, Martin, Amato & Crusio, 2011). Interestingly, 
Markham and colleagues (2006) found male KO mice had protracted responses to 30 
minutes of restraint when compared to WT mice, using mice of a C57/Bl6 background; 
however Qin and Smith (2008) did not find any genotype differences after the same 
stressor when using FVB/NJ male mice. However, clearly, there may have been other 
methodological differences between the studies which caused the differences in the 
results (see Table 1 for summary of key study methodology). For instance, the timings 
of the testing of the animals (when specified) varied between 7am and 2pm. The active 
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phase of mice is typically during the night time, inverse to humans, with a peak at 
approximately 8pm (Gong et al, 2015), though of course housing and lighting conditions 
may cause this to vary. The time widows for testing across the reviewed studies 
overlapped substantially making comparisons challenging. However, this possible 
influence should be considered in future research and there is a need to establish better 
evidence on the link between sample timings, circadian rhythmicity and stress-related 
corticosterone release in FMR1 KO mice, in order to facilitate the interpretation of the 
literature.  
Duration of response. Next, several studies have investigated the duration of 
corticosterone responses. This was achieved by conducting timecourse studies 
involving sacrificing groups of mice at differing lengths of time following a restraint 
stressor. Interestingly, Markham and colleagues (2006) observed that the male KO 
animals showed a slower return to unstressed baseline than WT; a pattern which is 
consistent with the prediction of reduced HPA negative feedback. Though, two other 
studies did not find any genotype differences between male animals in response 
duration (Nielsen et al, 2009; Qin & Smith, 2008).  
Gender differences. One study was identified which included female mice 
(Markham et al, 2006; gender comparisons summarised in Table 4). In this research, no 
difference was found in peak responding between male and female KO mice, following 
physical restraint for 30 minutes. However, female KO mice showed a different pattern 
of response and recovery to their male counterparts, but also atypical compared to the 
WT mice: the female KO mice appeared to show a protracted rise, as their the peak 
corticosterone level was at the final 60m sample, where levels would be expected to be 
falling (there were no gender differences in the WT animals). This suggests that animal 
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gender may play an important role in the outcomes of research into HPA output in FXS. 
However, further research is needed.  
 Human literature. Four studies to date have investigated group differences in 
the release of cortisol in response to cognitive, behavioural or physical testing (see 
Table 2 for details of study participant characteristics and Table 3 for details of 
between-group comparisons). Preliminary evidence for atypical regulation is provided 
by a case study of an adult male (age 24 years) with FXS who showed an atypical 
pattern of adaptation in response to physical exercise: an early increase in cortisol 
followed by a large decrease, opposite to the pattern of adaptation seen in the healthy 
controls (15 males; Bricout et al, 2008). Larger studies have also evaluated differences 
in the magnitude of cortisol reactions, focussing particularly on the response to social 
stressors (due to the atypical social behaviour associated with the syndrome). The 
findings of these studies are mixed. Firstly, Hessl and colleagues (2002) observed that 
males with FXS (70, age 6-17 years) showed reduced diurnal decline in the period after 
meeting unfamiliar researchers, compared to the siblings (58 female, 51 male, age 6-17 
years), which the authors suggested may have resulted from an increased response to 
this social challenge. In addition, Scherr and colleagues (2016) found that, in the first 
year of the longitudinal study, boys with FXS (31, age 9-14 years) showed higher levels 
of reactant cortisol following an assessment battery, when compared to TD controls (49, 
matched on non-verbal mental age, 4-9 years). These differences were not observed in 
the following two assessment years, in which fewer individuals participated (Scherr, 
2013). In addition, levels of baseline cortisol were higher in the FXS group than the 
comparison group, though this difference did not reach a level of statistical significance. 
In addition, the authors noted differences in the changes of cortisol levels over the 
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longitudinal assessment.  Firstly, the degree of change in cortisol levels over the years of 
the longitudinal assessment (reactant minus baseline levels) increased in the FXS group, 
as compared to the TD controls. Visual analysis suggested that the baseline levels of 
cortisol increased over the years of assessment in the FXS group, but not the TD group. 
As such, the evidence from these two studies, as well as the aforementioned case study, 
suggest possible differences in the responses of boys with FXS, as well as differences in 
the development of this regulation over time.  
However group differences were not observed in all studies. Further analysis of 
the data collected in the study by Hessl and colleagues (2002), did not find any 
differences between the children with FXS and unaffected siblings in cortisol levels in 
response to, or following, a structured social challenge (Hessl et al, 2006. FXS group: 58 
males, 32 females, age 6-17 years. Sibling group: 53 females, 37 males, age 6-17 years). 
Finally, Roberts and colleagues (2009) conducted an evaluation of 51 males with FXS 
(mean age 3 years) compared to 21 male TD controls (mean age 4 years) investigated 
the magnitude of cortisol responses to a social interaction between children with FXS 
and their siblings without FXS, though divided the FXS group according to degree of 
autism symptomatology in their analysis. It was found that, although there were no 
differences between young boys with FXS and low levels of autism symptomatology 
(who did not meet the criteria for a dual diagnosis of autism spectrum disorder on the 
CARS) and their siblings, children with FXS and high levels of autism symptomatology 
had higher levels of cortisol both prior to and following social interactions with an 
unfamiliar experimenter (though there were no differences in the magnitude of the 
response). This suggests that there may be differences in cortisol profiles within the 
population of people with FXS, relating to the degree of autistic symptomatology. The 
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relationship between cortisol and autism symptomatology is discussed in further detail 
later in this review.  
Thus, as with the findings in the preclinical literature, the findings of the studies 
in humans are heterogeneous. However, where differences were observed between the Ǯǯ	ǡ
manifested as relative increases, rather than decreases, in cortisol secretion. This 
corresponds to the preclinical observations of comparatively higher corticosterone 
responses to stressors in FMR1 KO mice in four studies; though, as mentioned above, 
seven studies found no genotype difference in these animals. However, this potential 
trend in the findings highlights an avenue for future investigation.  
Gender differences. Given the broad gender differences in the manifestation of 
FXS, researchers have chosen to investigate whether there are differences in cortisol 
responses between males and females with FXS, in four studies. In two studies, it was 
observed that males showed higher levels of cortisol following social challenges (a brief 
social stressor: Wisbeck et al, 2000; interaction with an unfamiliar experimenter: Hessl 
et al, 2002) than females. This suggests that atypical responding may be limited to, or at 
least exaggerated, in males with FXS, compared to females with the condition, mirroring 
the observations in the preclinical literature on the topic. Of note, however, the 
differences in both studies were based on visual observances and were not statistically 
evaluated.  In contrast, both Hessl and colleagues (2006) and Hall and colleagues (2008: 
29 females and 31 males, age 5-20 years) found no gender differences in their studies, 
where statistical comparisons were conducted. Namely, Hessl and colleagues (2006) 
found no differences in the magnitude of response to a social challenge and Hall and 
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colleagues (2008) saw no differences in diurnal decline across a day which involved 
unfamiliar social interactions in the form of evaluations by the experimenters.  
Therefore, the results between studies are mixed, which may, in part, reflect the 
higher variability in the presentation of FXS in females, resulting from processes such as 
X-inactivation. Though, in the wider literature, there is evidence of gender-related 
differences in HPA in adulthood, though it is unclear whether robust differences exist in 
younger individuals (Jessop & Turner-Cobb, 2008), such as those included in the studies 
in FXS. It is possible that there are also FXS-independent differences which contribute to 
this gender dimorphism. More detailed exploration of the relationship between other 
biomarkers (such as FMRP), cortisol and behaviour in males and females with FXS may 
help to clarify the origins of this variability and verify whether differences do exist.  
Is there a Relationship Between Cortisol Levels and Behaviour within Fragile X 
Syndrome? 
Animal literature. To date, there has been no research to date investigating 
whether individual differences in corticosterone responses relate to differences in 
behaviour. Though, it is unclear how such research may translate to understanding of 
human behaviour as the behavioural phenotype of the mouse model does not 
correspond closely to that of the human phenotype. Namely, in comparison to the 
increased levels of anxiety associated with FXS in humans (for instance; Cordiero et al, 
2011), all studies which utilised a behavioural assay to assess anxiety (Elevated Plus 
Maze; Pellow, Chopin, File & Briley, 1985) observed that FMR1 KO mice exhibit 
decreased behavioural indicators of anxiety relative to their WT counterparts (Qin et al, 
2011; de Diego-Otero et al, 2008; Qin & Smith, 2008; Eadie et al, 2009). No research has 
been conducted to identify which mouse behaviours correspond to clinically significant 
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behaviours in FXS. However, should these be identified, animal models may help to 
highlight relationships between HPA axis function and behaviour in FXS.   
Human literature. Five studies conducted within-group comparisons to 
investigate the relationship between salivary cortisol and measures of behaviour in 
individuals with FXS (see Table 2 for participant details and Table 5 for study details).  
Social and Autistic Behaviours. Many people with FXS display autistic-like 
characteristics including: gaze-avoidance, repetitive behaviour and shyness. However, 
not all individuals with FXS display levels of autistic symptomatology which mean that 
they meet the diagnostic criteria for an autism spectrum disorder (Talisa et al, 2014). As 
such, a number of studies have investigated possible factors associated with the degree 
of autism symptomatology, including salivary cortisol.  
 Three studies which have utilised observational measures of behaviours 
exhibited by individuals with FXS, during various types of social interaction. Two of 
these studies, utilising the same group of participants, observed the behaviour of 
individuals with FXS during a structured social challenge, which involved asking the 
child to read, answer questions and sing in front of others (Hall et al, 2006; Hessl et al, 
2006). Many of the measured behaviours were not found to have relationships with 
cortisol levels including: vocal quality (including mumbling or intrusive tones: Hessl et 
al, 2006) discomfort (participant appears in crisis, demonstrating behaviours such as 
self-injury, crying, aggression: Hessl et al, 2006. Hand-biting was also assessed 
separately in: Hall et al, 2006) non-verbal task avoidance (physically leaving the 
situation or covering eyes; Hessl et al, 2006; Hall et al, 2006), verbal refusals (Hall et al, 
2006). Though, a positive correlation was observed with fidgeting (Hall et al 2006). 
Most interestingly, however, gaze avoidance, one of the characteristic features of the 
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FXS phenotype, was found to relate to levels of cortisol in both studies, though the 
direction of the associations differed. Hessl and colleagues (2006) found that (across 
males and females with FXS), after controlling for other potential influences on cortisol 
levels, increased gaze aversion was associated with a lower post-challenge levels, to the 
social challenge. In fact, it was noted that the most gaze aversive children exhibited 
decreases in eye contact in response to the challenge. In contrast, Hall and colleagues 
(2006) found that increased mean levels of cortisol were associated with decreased eye 
contact. However, these findings raise two hypotheses as to whether the primary 
influence on gaze avoidance relates to autistic-like characteristics (i.e. a lack of response 
to social stimuli) or social anxiety (i.e. an excessive response to social stimuli; Hessl et 
al; 2006). Both hypotheses are interesting and warrant further investigation.  
Furthermore, the relationship between salivary cortisol and social approach 
behaviour during naturalistic social interactions has been explored in one study 
(Roberts et al, 2009). The method involved investigating social approach behaviour 
(physical approach, facial expressions and eye contact) with an experimenter when they 
were both unfamiliar (first minute of interaction) and familiar (during last hour of day-
long assessment) to the child. Typically, as also seen in the controls in this study, 
children who approach an unfamiliar person more show an increased reaction and 
those who later approach the experimenter more (when familiar) initially had higher 
baseline levels of cortisol. However, the children with FXS showed a different pattern of 
association in this study. Firstly, the participants with FXS and low levels of autism 
symptomatology showed no significant association between cortisol and behaviour at 
all. Whereas, within the group of children with FXS and high levels of autism 
symptomatology, boys with higher cortisol levels (following the interaction) showed 
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fewer physical approaches to the unfamiliar experimenter: the opposite pattern to in 
the control group. As such, this study suggests a possible association between 
heightened physiological reactions to social situations, and increased social avoidance.  
 Further evidence on the association between cortisol and autistic behaviour in 
FXS comes from studies which have utilised broader autism screening or diagnostic 
measures. Hall and colleagues (2008) utilised a direct observational assessment 
measure (ADOS-G; Lord, Rutter, DiLavore, & Risi, 2002) with their participants. The 
results of the study indicated that lower baseline levels of cortisol were associated with 
higher levels of autistic behaviour. Hessl and colleagues (2006) also found a 
relationship between cortisol and some types of autistic behaviour: increased sensory 
and social relation problems were positively associated with cortisol reactivity to a 
social challenge. Roberts and colleagues (2009), in contrast, found that reduced cortisol 
reactivity (which the authors suggest could be related to elevated basal levels) to a 
social interaction was associated with increased autistic behaviour (as measured on a 
behaviour rating scale: CARS; Schopler, Reicher & Renner, 1980), only within the group 
of individuals with FXS and high levels of autism symptomatology; in the group of 
children with FXS and low levels of autism symptomatology, there was no relationship 
between cortisol and levels of autistic behaviour.  
As such, a number of studies highlight associations between HPA activity and 
this key part of the FXS behavioural phenotype. However, the nature and direction of 
this association varies, with some finding increased levels of cortisol to be associated 
with increased autism symptomatology, both other with decreased cortisol levels. The 
heterogeneity of measures behaviour (direct observation as compared to informant 
rating scales) and cortisol may underlie such differences. In addition, the findings of 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      22 
 
Roberts and colleagues (2009) raise the possibility that levels of cortisol more strongly 
relate to behaviour in individuals with FXS and high autism symptomatology, as 
compared to those with lower symptomatology. In fact, the authors suggest that HPA 
dysregulation may serve as a biomarker of ASD in FXS. ǯ
levels of autistic behaviour may be important to consider when interpreting the results 
of studies of the relationship between cortisol and behaviour in FXS. Though, variations 
in the assessment of autistic behaviour across the other reviewed studies make it 
challenging to evaluate this further based on the existing evidence. Future research to 
study the gradation of ASD in FXS would be valuable to delineate phenotypic 
boundaries and evaluate the significance of HPA function as a biomarker of ASD in FXS.  
There is a growing body of literature relating to idiopathic autism which is also 
of relevance to this discussion. A review of this literature, revealed differences in both 
HPA rhythm and responsiveness in individuals with autism (Taylor & Corbett, 2014). 
Typically, in response to social situations, individuals with autism exhibit blunted 
responsiveness, which corresponds to the patterns seen by both Hall and colleagues 
(2008) and Hessl and colleagues (2006). Interestingly, however, the differences 
observed in those with idiopathic autism seem to be moderated by levels of functioning: 
there is not conclusive evidence that HPA dysregulation observed in lower functioning 
individuals also applies to individuals with high functioning autism. In Roberts and ǯǡ	high levels of autism 
symptomatology had lower levels of adaptive behaviour than those with low levels of 
autism symptomatology (though the significance of the difference was not evaluated), 
highlighting a potential confound. Future research should examine this potential 
relationship in the FXS population.  
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 A broader question relating to the question of the association between autistic 
behaviour in FXS is the debate as to whether autistic-like behaviours in individuals with 
FXS meaningfully correspond to the characteristics seen with idiopathic autism (Hall et 
al, 2010). It is possible that autistic-like behaviours in FXS have different causal 
mechanisms and, as such, the relationships between cortisol and behaviour may differ 
in those with syndromic and non-syndromic autistic characteristics. Future research 
might help to address these issues. For instance, comparison of the relationships 
between cortisol and behaviour in those with autism, including those with non-
syndromic autism and those with FXS who meet the criteria for autism, may help to 
elucidate whether cortisol and behaviour relations differ in their nature or 
development, dependent upon genetic status.  
 Behaviour problems. Behavioural problems and challenging behaviours are a key 
issue of concern for many caregivers of people with FXS. Such behavioural issues are Ǯǯǡ
investigations between these behaviours and physiological responses are warranted. In 
order to explore this issue, two studies have utilised the Child Behaviour Checklist 
(CBCL; Achenbach, 1991) as a broad measure of behaviour problems, and explored 
relations between scores and cortisol levels. Hessl and colleagues (2002; controlling for 
other factors which were found to be predictive of the scores) found that a composite 
score of cortisol significantly predicted 14% of the variance in total behaviour problem 
scores for females with FXS. Further analyses indicated that increased cortisol levels 
were specifically associated with increased social and attention problems. Furthermore, 
a composite score representing cortisol secretion on typical days significantly positively 
correlated with attention problems and approached significance for somatic complaints 
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and social problems. There were no other relationships between cortisol and other of 
the measured behaviour problems, including: withdrawn behaviour, anxious or 
depressed behaviour, thought problems, aggressive behaviour or delinquent behaviour. 
In the same study cortisol levels accounted for 8% of variance in total behaviour 
problems in the males with FXS, which approached significance. The strongest 
association with a subscale score was with withdrawn behaviour. In comparison, in a 
later study with the same participants (Hessl et al, 2006), no relationship was found 
between CBCL scores and any cortisol measures (baseline, post-challenge cortisol or 
magnitude of change) taken in relation to a social challenge. 
 Other Characteristics. Scherr and colleagues (2016) found that increased 
baseline levels of cortisol were associated with lower verbal working memory 
performance in boys with FXS, suggesting a possible link between arousal levels and 
academic-related performance.  
Synthesis and Future Research 
There are some interesting preliminary findings in this existing research. Though 
the findings are heterogeneous, there are some interesting observations and trends 
within the relatively few studies that have addressed the issue of HPA function in FXS, 
to date. In mice, no robust differences in baseline cortisol levels were seen, though there 
was some evidence of elevated stress-related reactivity. In human studies, baseline 
differences were observed in several studies (Hessl et al 2002; 2006; Roberts et al, 
2009), as well as some indications of reactivity differences, compared to TD children 
(Scherr et al, 2016; Hessl et al, 2002; Roberts et al, 2009), though such differences may 
be mediated by gender and degree of autism symptomatology. At present, specific 
conclusions about the role of cortisol levels in behaviour associated with FXS are 
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difficult to draw due to the high levels of variability and lack of correspondence 
between studies. However, there are suggestions of associations between cortisol levels 
and autistic behaviour, behaviour problems and key cognitive processes (working 
memory). Future research will undoubtedly help to clarify some of these uncertainties 
and strengthen the evidence to clarify the robustness of the observed themes.  
In addition to the suggestions discussed through the previous sections, there are several 
other considerations for future projects. The wider information on the HPA system 
highlights its complexity, with individual differences relating to multiple factors, 
including: medication, pubertal stage, gender, temperament, chronic stress, compliance 
with the sampling protocol, nature of stressors, familial genetics and BMI (Jessop & 
Turner-Cobb, 2008; Gunnar et al, 2003; Dickerson & Kemeny, 2004; Kupper et al, 2005). 
As well as the variation in study methodology, many of these potential influences have 
not been explored or accounted for in the research and may relate to the observed 
variability in study findings. Furthermore, the research to date has provided important 
but limited snapshots of the activity of the HPA axis, with the exception of Scherr and ǯȋ ? ? ? ?Ȍǡ in small groups of individuals. Prospective or ǯ characteristics, 
behaviour, environment and biology would help to provide a more detailed picture of 
the role of HPA activity in this population. 
In addition, research involving humans has utilised TD comparison groups. 
However, an important step in future research will be to investigate the specificity of 
any group differences to individuals with FXS. It is possible that, rather than being 
directly FXS-related, the differences observed could relate to having an intellectual 
disability or autistic behaviour, and may be seen in others without FXS, but with similar 
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characteristics. For instance, earlier research with people with autism has highlighted 
that level of cognitive functioning relates to the findings: with differences being ǲǳȋǡ ? ? ? ?Ǣ
Corbett et al, 2006; Richdate & Prior, 1992; Taylor & Corbett, 2014). In addition, given 
the aforementioned potential link also between levels of autism symptomatology and 
cortisol levels in those without FXS, and the high levels of autistic behaviour seen in 
people with FXS (Clifford et al, 2007), this clearly may be a confound in the differences 
seen. This is particularly pertinent given the findings of Roberts and colleagues (2009), 
who found that cortisol differences in FXS, compared to TD controls, was dependent 
upon levels of autism symptomatology. Thus, future research should employ control 
groups to help address these potential confounds, including those with non-syndromic 
autism and those with idiopathic intellectual disabilities.  
In addition, in the human literature discussed above, much of the focus has been 
upon investigating HPA responses relating to social interactions or demands, in 
individuals with FXS. Given that individuals with FXS are prone to experiencing 
exaggerated behavioural responses, anxiety or phobias relating to many, varied 
situations (Cordeiro, Ballinger, Hagerman & Hessl, 2011), it is possible that 
idiosyncratic circumstances (outside of the examined social challenges or interactions) 
may also trigger cortisol responses that differ in magnitude or duration, compared to 
the general population. For instance, individuals with FXS are known to experience 
atypical sensory processing (Belser & Sudhalter, 1995) and have been shown to show 
elevated startle responses to sensory stimuli (Miller et al, 1999). Of note, research with 
individuals with autism has highlighted differential patterns of reactions to social-
evaluative and non-social (such as unpleasant sensations) stimuli (Taylor & Corbett, 
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2014). Therefore, future research should address cortisol responses to a wider variety 
of situations which may be challenging for individuals with FXS, in order to gain a 
broader picture of HPA activity in this populationǡǯ-
to-day challenges.   
Finally, given the possible significance of arousal differences, as evidenced by 
potential links with cognition and behaviour, researchers should also evaluate potential 
strategies for managing levels of arousal and systematically assess for any resultant 
improvements more widely. Scherr and colleagues (2016) highlight that individuals 
with FXS may benefit from targeted arousal-reducing interventions, such as the 
teaching of coping skills or relaxation techniques. This could include, for instance, the 
use of mindfulness-based techniques, which have been shown to reduce levels of 
arousal in individuals with Williams Syndrome (Miodrag et al., 2013).  There has been a 
paucity of systematic evaluations of potential interventions for arousal issues in 
individuals with FXS, which include physiological measures, such as assessment of 
cortisol. However, Hall and colleagues (Hall, Lightbody, McCarthy, Parker, & Reiss, 
2012) piloted intranasal oxytocin as an intervention for social anxiety in a small group 
of boys with FXS and found both increases in eye contact and decreases in cortisol levels 
after administration. This suggests that there may be avenues for both 
pharmacotherapy and behavioural interventions when seeking ways to support 
individuals with FXS in this area.  
Conclusion  
In summary, there is emerging evidence that cortisol levels differ in individuals 
with FXS compared to TD controls and relate to socially significant behaviours, thus 
highlighting a number of important avenues for future exploration. Delineating the 
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significance and role of HPA activity in the syndrome will help to further our 
understanding of the mechanisms of the condition and may lead to provision of more 












Achenbach, T. M., & Edelbrock, C. S. (2001). Child behavior checklist. Burlington VT. 
Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior 
checklist: a behavior rating scale for the assessment of treatment 
effects. American Journal of Mental Deficiency, 89 (5), 485-491. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      29 
 
Bailey, D. B., Mesibov, G. B., Hatton, D. D., Clark, R. D., Roberts, J. E., & Mayhew, L. (1998). 
Autistic behaviour in young boys with fragile x syndrome. Journal of Autism and 
Developmental Disorders, 28 (6), 499-508.  
Bailey, D. B., Raspa, M., Olmsted, M., & Holiday, D. B. (2008). Co-occurring conditions 
associated with FMR1 gene variations: Findings from a national parent survey. 
American Journal of Medical Genetics, 146A (16), 2060-2069. 
Barrett, E. J. (2009). The adrenal gland. In Boron, W. F., & Boulpaep, E. L. (Eds.), Medical 
Physiology (5th Ed.; 1057-1073). Philadelphia, PA: Saunders Elsevier.  
Bear, M.F. (1998) The role of LTD and LTP in development and learning. In Mechanistic 
Relationships between Development and Learning (Carew, T.J. et al., eds), pp. 
205Ȃ225, Wiley.  
Beaton, E. A., Schmidt, L. A., Schulkin, J., & Hall, G. B. (2013). Repeated measurement of 
salivary cortisol within and across days among shy young adults. Personality and 
Individual Differences, 55(6), 705-710. 
Bodfish, J. W., Crawford, T. W., Powell, S. B., & Parker, D. E. (1995). Compulsions in 
adults with mental retardation: Prevalence, phenomenology, and comorbidity 
with stereotypy and self-injury. American Journal on Mental Retardation, 100 (2), 
183-192 
Braat S, Kooy, R.F.  (2015). The GABA-A receptor as a therapeutic target for 
neurodevelopmental disorders.  Neuron, 8, 1119-1130. 
Bregman, J. D., Leckman, J. F., & Rot, S. I. (1990). Thyroid function in Fragile-X syndrome 
males. Yale Journal of Biological Medicine, 63, 293-299.  
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      30 
 
Bricout, V. A., Flore, P., Eberhard, Y., Faure, P., Guinot, M., & Favre-Juvin, A. (2008, 
November). Maximal and submaximal treadmill tests in a young adult with 
fragile-X syndrome. In Annales de réadaptation et de médecine physique (Vol. 51, 
No. 8, pp. 683-691). Elsevier Masson. 
ǤǤǤǡǡ
ǤǤǡǯǡǤǤǡǡǡ
Cappellen G.W.A., Houtsmuller A.B., Willemsen R, de Zeeuw C.I, Bahn S. (2016). 
Synaptic vesicle dynamic changes in a model of fragile X.  Molecular autism, 7, 17-
27. 
Butler, M. G., Najjar, J. L., Opitz, J. M., & Reynolds, J. F. (1988). Do some patients with 
fragile X syndrome have precocious puberty?. American journal of medical 
genetics, 31(4), 779-781. 
Clifford, S., Dissanayake, C., Bui, Q. M., Huggins, R., Taylor, A. K., & Loesch, D. Z. (2007). 
Autism spectrum phenotype in males and females with fragile X full mutation 
and premutation. Journal of autism and developmental disorders, 37(4), 738-747. 
Cohen, I. L. (1995). A theoretical analysis of the role of hyperarousal in the learning and 
behaviour of fragile x males. Mental Retardation and Developmental Disabilities 
Research Reviews, 1, 286-291. 
Corbett, B. A., Mendoza, S., Abdullah, M., Wegelin, J. A., & Levine, S. (2006). Cortisol 
circadian rhythms and response to stress in children with 
autism. Psychoneuroendocrinology, 31(1), 59-68. 
Cordeiro, L., Ballinger, E., Hagerman, R., & Hessl, D. (2011). Clinical assessment of DSM-
IV anxiety disorders in fragile X syndrome: prevalence and 
characterization. Journal of Neurodevelopmental Disorders, 3(1), 57-67. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      31 
 
de Diego-Otero, Y., Romero-Zerbo, Y., el Bekay, R., Decara, J., Sanchez, L., Rodriguez-de 
Fonseca, F., & del Arco-ǡǤȋ ? ? ? ?ȌǤȽ-Tocopherol protects against 
oxidative stress in the fragile X knockout mouse: an experimental therapeutic 
approach for the FMR1 deficiency. Neuropsychopharmacology,34(4), 1011-1026. 
Dickerson, S. S., & Kemeny, M. E. (2004). Acute stressors and cortisol responses: a 
theoretical integration and synthesis of laboratory research. Psychological 
bulletin, 130(3), 355. 
Eadie, B. D., Zhang, W. N., Boehme, F., Gil-Mohapel, J., Kainer, L., Simpson, J. M., & 
Christie, B. R. (2009). FMR1 knockout mice show reduced anxiety and alterations 
in neurogenesis that are specific to the ventral dentate gyrus. Neurobiology of 
Disease, 36(2), 361-373. 
Feng, Y., Gutekunst, C. A., Eberhart, D. E., Yi, H., Warren, S. T., & Hersch, S. M.(1997). 
Fragile X mental retardation protein: Nucleocytoplasmic shuttling and 
association with somatodendritic ribosomes. Journal of Neuroscience, 17 (5), 
1539-1547. 
Fu, Y. H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkerk, A. J. M. 
H., Holden, J. J. A., Fenwick, R. G., Warren S. T., Oostra, B. A., Nelson, D. L., & 
Caskey, C. T. (1991). Variation of the cgg repeat at the fragile-X site results in 
genetic instability - resolution of the sherman paradox. Cell, 67(6), 1047-1058.  
Ghilan, M., Hryciw, B. N., Brocardo, P. S., Bostrom, C. A., Gil-Mohapel, J., & Christie, B. R. 
(2015). Enhanced corticosteroid signaling alters synaptic plasticity in the 
dentate gyrus in mice lacking the fragile X mental retardation 
protein. Neurobiology of disease, 77, 26-34. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      32 
 
Goldsmith, H. H., & Lemery, K. S. (2000). Linking temperamental fearfulness and anxiety 
symptoms: A behaviorȂgenetic perspective. Biological Psychiatry, 48(12), 1199-
1209. 
Gong, S., Miao, Y. L., Jiao, G. Z., Sun, M. J., Li, H., Lin, J., Lou, M-J., & Tan, J. H. (2015). 
Dynamics and correlation of serum cortisol and corticosterone under different 
physiological or stressful conditions in mice. PloS one, 10(2), e0117503. 
Grissom, N., & Bhatnagar, S. (2009). Habituation to repeated stress: get used to 
it. Neurobiology of learning and memory, 92(2), 215-224. 
Gunnar, M. R. (1987). Special edition on psychobiological studies of stress and coping- 
An introduction. Child Development, 58, 6, 1403-1407.  
Gunnar, M. R., Sebanc, A. M., Tout, K., Donzella, B., & van Dulmen, M. M. (2003). Peer 
rejection, temperament, and cortisol activity in preschoolers. Developmental 
psychobiology, 43(4), 346-368. 
Hall, S. S., Lightbody, A. A., & Reiss, A. L. (2008). Compulsive, self-injurious, and autistic 
behavior in children and adolescents with fragile X syndrome. American Journal 
on Mental Retardation, 113(1), 44-53.  
Hall, S. S., Lightbody, A. A., Huffman, L. C., Lazzeroni, L. C., & Reiss, A. L. (2009). 
Physiological correlates of social avoidance behavior in children and adolescents 
with fragile X syndrome. Journal of the American Academy of Child & Adolescent 
Psychiatry, 48(3), 320-329. 
Hall, S. S., Lightbody, A. A., Hirt, M., Rezvani, A., & Reiss, A. L. (2010). Autism in fragile X 
syndrome: a category mistake?. Journal of the American Academy of Child & 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      33 
 
Adolescent Psychiatry, 49(9), 921-933.Hall, S. S., Lightbody, A. A., McCarthy, B. E., 
Parker, K. J., & Reiss, A. L. (2012). Effects of intranasal oxytocin on social anxiety 
in males with fragile X syndrome. Psychoneuroendocrinology, 37(4), 509-518. 
Herbert, J. D., Bellack, A. S., & Hope, D. A. (1991). Concurrent validity of the social phobia 
and anxiety inventory. Journal of Psychopathology and Behavioral 
Assessment, 13(4), 357-368. 
Herman, J. P., & Cullinan, W. E. (1997). Neurocircuitry of stress: central control of the 
hypothalamo-pituitary-adrenocortical axis. Trends in Neuroscience, 20 (2), 78-84.  
Hessl, D., Glaser, B., Dyer-Friedman, J., Blasey, C., Hastie, T., Gunnar, M., & Reiss, A. L. 
(2002). Cortisol and behavior in fragile X syndrome. 
Psychoneuroendocrinology, 27(7), 855-872. 
Hessl, D., Riviera, S. M., & Reiss, A. L. (2004). The neuroanatomy and 
neuroendocrinology of fragile x syndrome. Mental Retardation Developmental 
Disabilities research reviews, 10 (1), 17-24.  
Hessl, D., Glaser, B., DyerǦFriedman, J., & Reiss, A. L. (2006). Social behavior and cortisol 
reactivity in children with fragile X syndrome. Journal of Child Psychology and 
Psychiatry, 47(6), 602-610. 
Hoshino, Y., Yokoyama, F., Watanabe, M., Murata, S., Kaneko, M., & Kumashiro, H. (1987). 
The diurnal variation and response to dexamethasone suppression test of saliva 
cortisol level in autistic children. Psychiatry and Clinical Neurosciences, 41(2), 
227-235. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      34 
 
Irwin, S. A., Galvez, R., & Greenough, W. T. (2000). Dendritic spine structural 
abnormalities in fragile-x mental retardation syndrome. Cerebral Cortex, 10(10), 
1038-1044. 
Jafari, M., Seese, R. R., Babayan, A. H., Gall, C. M., & Lauterborn, J. C. (2012). 
Glucocorticoid receptors are localized to dendritic spines and influence local 
actin signaling. Molecular neurobiology, 46(2), 304-315. 
Jessop D. S. (1999). Review: central non-glucocorticoid inhibitors of the hypothalamo-
pituitary-adrenal axis. Journal of Endocrinology, 160, 169-180. 
Jessop, D. S., & Turner-Cobb, J. M. (2008). Measurement and meaning of salivary 
cortisol: A focus on health and disease in children: Review. Stress: The 
International Journal on the Biology of Stress, 11(1), 1-14. 
Kagan, J., Reznick, J. S., & Snidman, N. (1988). Biological bases of childhood 
shyness. Science, 240 (4849), 167-171. 
Kelly, W. F., Kelly, M. J., &  Faragher, B. (2003). A prospective study of psychiatric and ǯǤClinical Endocrinology, 45(6), 715-
720. 
Khandjian, E. W., Corbin, F., Woerly, S., & Rousseau, F. (1996) The fragile X mental 
retardation protein is associated with ribosomes. Nature Genetics, 12 (1), 91-93. 
Kim, S. Y., Burris, J., Bassal, F., Koldewyn, K., Chattarji, S., Tassone, F., Hessl, D., & Rivera, 
S. M. (2012). Fear-specific amygdala function in children and adolescents on the 
fragile x spectrum: a dosage response of the FMR1 gene. Cerebral cortex, bhs341. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      35 
 
Kowalczyk C. L., Schroeder, E., Pratt, V., Conard, J., Wright, K., & Feldman, G. L. (1996). An 
association between precocious puberty and fragile X syndrome? Journal of 
Pediatric and Adolescent Gynecology, 9, 199Ȃ202.  
Krug, D.A., Arick, J.R., & Almond, P.J. (1993). Autism Screening Instrument for 
Educational Planning: An assessment and educational planning system for 
autism and developmental disabilities (2nd edn). Austin, TX: Pro-Ed. 
Kupper, N., de Geus, E. J., van den Berg, M., Kirschbaum, C., Boomsma, D. I., & Willemsen, 
G. (2005). Familial influences on basal salivary cortisol in an adult 
population. Psychoneuroendocrinology, 30(9), 857-868. 
Lachiewicz, A. M., Spiridigliozzi, G. A., Gullion, C., Ransford, S. N., & Rao, K. (1994). 
Aberrant behaviours of young boys with fragile X syndrome. American Journal on 
Mental Retardation, 98 (5), 567-579. 
Lauterborn, J. C. (2004). Stress induced changes in cortical and hypothalamic c-fos 
expression are altered in fragile X mutant mice. Molecular brain research, 131(1), 
101-109. 
Lord, C., Risi, S., Lambrecht, L., Cook Jr, E. H., Leventhal, B. L., DiLavore, P. C., Pickles. A., & 
Rutter, M. (2000). The Autism Diagnostic Observation ScheduleȄGeneric: A 
standard measure of social and communication deficits associated with the 
spectrum of autism. Journal of autism and developmental disorders,30(3), 205-
223.Markham, J. A., Beckel-Mitchener, A. C., Estrada, C. M., & Greenough, W. T. 
(2006). Corticosterone response to acute stress in a mouse model of Fragile X 
syndrome. Psychoneuroendocrinology, 31(6), 781-785. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      36 
 
McEwen, B.S. (1998). Protective and damaging effects of stress mediators. New England 
Journal of Medicine, 338, 171Ȃ179. 
Miller, G. E., Chen, E., & Zhou, E. S. (2007). If it goes up, must it come down? Chronic 
stress and the hypothalamic-pituitary-adrenocortical axis in humans. 
Psychological bulletin, 133(1), 25Miller, L. J., McIntosh, D. N., McGrath, J., Shyu, V., 
Lampe, M., Taylor, A. K., Tassone, F., Neitzel, K., Stackhouse, T., & Hagerman, R. J. 
(1999). Electrodermal responses to sensory stimuli in individuals with fragile X 
syndrome: a preliminary report. American journal of medical genetics, 83(4), 268-
279. 
Miodrag, N., Lense, M. D., & Dykens, E. M. (2013). A pilot study of a mindfulness   
intervention for individuals with Williams syndrome: Physiological outcomes. 
Mindfulness, 4 (2), 137̽147 
Miyashiro, K. Y., Beckel-Mitchener, A., Purk, T. P., Becker, K.. G., Barrett, T., Liu, L., 
Carbonetto, S., Weiler, I. J., Greenough, W. T., &  Eberwine, J. (2003). RNA Cargoes 
Associating with FMRP Reveal Deficits in Cellular Functioning in FMR1 Null Mice. 
Neuron, 37 (3), 417-431.  
Moore, P. S. J., Chudley, A. E., & Winter, J. S. D. (1990). True precocious puberty in a girl 
with fragile x syndrome. American Journal of Medical Genetics, 37 (2), 265-267. 
Muhle, R., Trentacoste, S. V., & Rapin, I. (2004). The genetics of autism. Pediatrics, 113, 
472-486. 
Nielsen, D. M., Evans, J. J., Derber, W. J., Johnston, K. A., Laudenslager, M. L., Crnic, L. S., & 
Maclean, K. N. (2009). Mouse model of fragile X syndrome: behavioral and 
hormonal response to stressors. Behavioral neuroscience, 123(3), 677. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      37 
 
Pellow, S., Chopin, P., File, S. E., Briley, M. (1985). Validation of open:closed arm entries 
in an elevated plus-maze as a measure of anxiety in the rat. Journal of 
Neuroscience Methods,14, 149Ȃ67. 
Pietropaolo, S., Guilleminot, A., Martin, B., D'Amato, F. R., & Crusio, W. E. (2011). Genetic-
background modulation of core and variable autistic-like symptoms in Fmr1 
knock-out mice. PLoS One, 6(2), e17073. 
Qin, M., & Smith, C. B. (2008). Unaltered hormonal response to stress in a mouse model 
of fragile X syndrome. Psychoneuroendocrinology, 33(6), 883-889. 
Qin, M., Xia, Z., Huang, T., & Smith, C. B. (2011). Effects of chronic immobilization stress 
on anxiety-like behavior and basolateral amygdala morphology in FMR1 
knockout mice. Neuroscience, 194, 282-290. 
Richdale, A. L., & Prior, M. R. (1992). Urinary cortisol circadian rhythm in a group of 
high-functioning children with autism. Journal of  Autism  and Developmental 
Disorders.  22(3), 433Ȃ47. 
Roberts, J. E., Weisenfeld, L. A. H., Hatton, D. D., Heath, M., & Kaufmann, W. E. (2007). 
Social approach and autistic behavior in children with fragile X 
syndrome. Journal of Autism and Developmental Disorders, 37(9), 1748-1760. 
Roberts, J. E., Clarke, M. A., Alcorn, K., Carter, J. C., Long, A. C., & Kaufmann, W. E. (2009). 
Autistic behavior in boys with fragile X syndrome: social approach and HPA-axis 
dysfunction. Journal of Neurodevelopmental Disorders, 1(4), 283-291.  
Rodrigues, S. M., Bauer, E. P., Farb, C. R., Schafe, G. E., & LeDoux, J. E. (2002). The group I 
metabotropic glutamate receptor mGluR5 is required for fear memory formation 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      38 
 
and long-term potentiation in the lateral amygdala. The Journal of 
neuroscience, 22(12), 5219-5229. 
Romero-Zerbo, Y., Descara, J., el Bekay, R., Sanchez-Salido, L., Arco-Herrera, I. D., de 
Fonseca, F. R., & de Diego-Otero (2009). Protective effects of melatonin against 
oxidative stress in FMR1 knockout mice: a therapeutic research model for the 
fragile X syndrome. Journal of Pineal Research, 46, 224-234.  
Scherr, J. F. (2013). Cortisol and Working Memory In Boys With Fragile X Syndrome. 
(Doctoral thesis, University of South Carolina, USA). Retrieved from: 
http://scholarcommons.sc.edu/cgi/viewcontent.cgi?article=3543&context=etd  
Scherr, J. F., Hahn, L. J., Hooper, S. R., Hatton, D., & Roberts, J. E. (2016). HPA axis function 
predicts development of working memory in boys with FXS. Brain and 
Cognition, 102, 80-90. 
Schmidt, L. A., Fox, N. A., Rubin, K. H., Sternberg, E. M., Gold, P. W., Smith, C. C., & 
Schulkin, J. (1997). Behavioral and neuroendocrine responses in shy 
children. Developmental Psychobiology, 30(2), 127-140. 
Schopler, E., Reichler, R. J., & Renner, B. R. (1986). The Childhood Autism Rating Scale 
(CARS): For diagnostic screening and classification of autism. New York: Irvington.  
Selye, H. (1956). The stress of life. New York: McGraw Hill. 
Shanks, N., Griffiths, J., Zalcman, S., Zacharko, R. M., & Anisman, H. (1990). Mouse strain 
differences in plasma corticosterone following uncontrollable 
footshock. Pharmacology Biochemistry and Behavior, 36(3), 515-519. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      39 
 
Sherman SL. (2002). Epidemiology. In: Hagerman RJ, Hagerman PJ, editors. Fragile X 
syndrome: Diagnosis, treatment and research. Baltimore: The Johns Hopkins 
University Press. p 136Ȃ168. 
Spratt, E. G., Nicholas, J. S., Brady, K. T., Carpenter, L. A., Hatcher, C. R., Meekins, K. A., 
Furlanetto, R. W., & Charles, J. M. (2012). Enhanced cortisol response to stress in 
children with autism. Journal of Autism and Developmental Disorders, 42, 75-81.  
Sullivan, K., Hooper, S., & Hatton, D. (2007). Behavioural equivalents of anxiety in 
children with fragile X syndrome: parent and teacher report. Journal of 
Intellectual Disability Research, 51(1), 54-65. 
Sun, H. T., Cohen, S., & Kaufmann, W. E. (2001). AnnexinǦ1 is abnormally expressed in 
Fragile X syndrome: TwoǦdimensional electrophoresis study in lymphocytes. 
American Journal of Medical Genetics, 103 (1), 81-90. 
Suvrathan, A., & Chattarji, S. (2011). Fragile X syndrome and the amygdala. Current 
opinion in neurobiology, 21(3), 509-515. 
Symons, F. J., Byiers, B. J., Raspa, M., Bishop, E., & Bailey, D. B. Jr. (2010). Self-injurious 
behaviour and fragile X syndrome: Findings from the national fragile X survey. 
American Association on Intellectual and Developmental Disabilities, 115 (6), 473-
481. 
Talisa, V. B., Boyle, L., Crafa, D., & Kaufmann, W. E. (2014). Autism and anxiety in males 
with fragile X syndrome: An exploratory analysis of neurobehavioral profiles 
from a parent survey. American Journal of Medical Genetics Part A, 164(5), 1198-
1203. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      40 
 
Taylor, J. L., & Corbett, B. A. (2014). A review of rhythm and responsiveness of cortisol in 
individuals with autism spectrum disorders. Psychoneuroendocrinology, 49, 207-
228. 
Turner, G., Webb, T., Wake, S., & Robinson, H. (1996). Prevalence of fragile X syndrome. 
American Journal of Medical Genetics, 64, 196-197. 
Van Cauter, E. (1990). Diurnal and Ultradian Rhythms in Human Endocrine Function: A 
minireview. Hormone Research, 34, 45-53. 
Verkerk, A. J. M.H., Pieretti, M., Sutcliffe, J. S., Fu, J. H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., 
Richards, S., Victoria, M. F., Zhang, F. P., Eussen, B. E., Vanommen, G. J. B., Blonden, 
L. A. J., Riggins, G. J., Chastain, J. L., Kunst, J. B., Galjaard, H., Caskey, C. T., Nelson, 
D. L., Oostra, B. A., & Warren, S. T. (2002). Identification of a gene (FMR-1) 
containing a cgg repeat coincident with a breakpoint cluster region exhibiting 
length variation in Fragile-X syndrome. Cell, 65 (5), 905-914.  
Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., 
Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997). Fragile X mental 
retardation protein is translated near synapses in response to neurotransmitter 
activation. Proceedings of the National Academy of Sciences of the United States of 
America, 94 (10), 5395-5400.Williams, Langdon & Porter, 2013 
Wisbeck, J. M., Huffman, L. C., Freund, L., Gunnar, M. R., Davis, E. P., & Reiss, A. L. (2000). 
Cortisol and social stressors in children with fragile X: A pilot study. Journal of 
Developmental & Behavioral Pediatrics, 21(4), 278-282. 
Woodcock, R. W., McGrew, K. S., Mather, N., & Schrank, F. (2001). Woodcock-Johnson III 
NU tests of achievement. Rolling Meadows, IL: Riverside Publishing. 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      41 
 
Zhang, J., Fang, Z., Jud, C., Vansteensel, M. J., Kaasik, K., Lee, C. C., Albrecht, U., Tamanini, 
F., Meijer, J. H., Oostra, B. A., & Nelson, D. L. (2008). Fragile X-related proteins 
regulate mammalian circadian behavioral rhythms. The American Journal of 
Human Genetics, 83(1), 43-52. 
 
 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      42 
 
Table 1 






































n by isoflurane 
M 7-18 C57Bl/6 55-65d / Restraint 
(conditions: 
15m/ 30m/ 







WT mice showed 
significant 
elevations only 
after 30m or 1h 















in KO mice 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      43 
 
de Diego-









M 8-12 FVB-129 60-180d / Social stress 
(15m) or acute 
immobilisatio













than WT. Acute 





























































elevated at 60 
m). Female show 
protracted rise 
compared to WT. 
peak secretion 
does not differ 
between 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 


















11-12w / Swim Stress 
(3m) or open 










































































120 m) or 
spatial novelty 














difference in any 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 



























































levels (not seen 
with vehicle or 
tianepetine) 
*= Information obtained from contact with author. -=data not available. /=not tested. w=weeks. d= days, m= minutes. h= hours. EPM= 
elevated plus maze. ns=non-significant 
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 



















© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Fragile X Syndrome HPA Axis      47 
 
Participant characteristics in studies investigating cortisol secretion in humans with Fragile X Syndrome 
Study FXS participants Control Participants 
N (M/F) Age Number with 
Autism 
N (M/F) Age Characteristics 
Bricout et al (2008) 1 M 24y N/A 15 (M)  - ǲǳ 











Friedman, & Reiss 
(2006) 
32 (F) 58 (M)* 
  
6-17y (Mean 10.89) 
 







of FXS or pre-
mutation using 
southern blot.) 
Hall, DeBernadis & 
Reiss (2006) 
40 (F) 74 (M)* 6-17y (male 
mean:11.06y, female 
mean 10.42y) 
N/A - - - 
Hall, Lightbody & 
Reiss (2008) 
29 (F) 31 (M) 5-20y (M mean: 13.21, F 
mean, 13.06) 
16 M and 6 F 
autism (23 M 
and 13 F 
autism 
spectrum) 
- - - 
Roberts et al (2009) 51 (M)  FXS-only- mean 3.99y; 
FXS+ASD+ mean 3.55y 
18 with 
autism 
21 (M) Mean: 4.05y Gender-matched 
typically developing 
(TD). No test FMR1 
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 status.  
Scherr, Hahn, Hooper, 
Hatton & Roberts 
(2016) 
31 (M)** 9.67-14.58y (Mean 12.4, 
SD 1.29) 
N/A 49 (M)** 4.92-9.5y 
(Mean 7.0y, 
SD 1.04y) 
TD, matched on non-
verbal mental age at 
beginning of 
longitudinal study. 
Wisbeck et al (2000) 
 
7 (F) 8(M) 
 
6-25y (M mean 13.5y, F 
mean 13.9y) 
 




Data analysed in 
same laboratory. 
ns= non-significant. m=minutes. y=years M=male, F=female  
*Note: same group of participants in three studies.  
**Sub-set of total study participants for whom cortisol data was available. 
+ Fragile X Syndrome and high levels of autism symptomatology (as indicated by a score on the Child Autism Rating Scale (CARS; 
Schopler, Reicher & Renner, 1988) above the cut-off for an autism spectrum disorder) 
-Fragile X Syndrome and low levels of autism symptomatology (as indicated by a score below the cut-off for an autism spectrum 
disorder on the CARS) 
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Table 3 
Comparisons of cortisol levels between groups of individuals with Fragile X Syndrome or comparison groups 
 Study Stressor Cortisol test  Cortisol Findings  
   Method Sample Timings Group comparisons 
Bricout et al (2008) Sub-maximal incremental 












FXS cortisol elevated during the first 20 minutes 
of the test (start inclusive) compared to controls 
and showed a decrease at exercise+40m, 
opposite to controls who showed an increase 
Hessl et al (2002) - Saliva (Salivette roll 
soaked 1-2 m). No 
citrus <30m, no dairy 
<60m 
 
Evaluation day. 30m 
after waking, during 
testing (11am), prior to 
social challenge 
(3.30pm), 30m after 
social challenge, 90m 
after social challenge, 
bedtime. Cortisol levels 
for each sample were 
standardised by z-score 
transformation and 
averaged across the 
evaluation day to create 
composite score. 
- 
Typical Day. Male FXS cortisol elevated 
compared to siblings on typical days (as 
indicated by reduced diurnal decline) but not 
females.  
Experimental day. Females did not differ from 
siblings. Males showed higher levels between 
pre-breakfast and pre-lunch samples.  
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2 consecutive typical 
non-school days. Within 
30m waking, before 
breakfast, one hour 
before lunch, one hour 
prior to dinner, bedtime. 
Cortisol levels for each 
sample were 
standardised by z-score 
transformation and 
averaged across the 
typical days to create 
composite score. 
Hessl, Glaser, Dyer-
Friedman, & Reiss (2006) 
Social Challenge (in home) 
modified from protocol 
used by Herbert, Bellack 
and Hope (1991). 
Counterbalanced 
presentation of one 15-
20m session of including 
the following conditions: 
child interview, silent 
reading, oral reading, 
singing.  
Saliva (Salivette cotton 
roll soaked 1-2 m). No 
citrus <30m, no dairy 
<60m 
 
2 samples: prior to 
social challenge (~3pm) 




FXS showed higher pre-challenge levels than 
siblings. No differences in degree of change or 
post-challenge levels. FXS participants showed 
increased cortisol through whole home 
assessment period (reported in Hessl et al 2002) 
Hall, DeBernadis & Reiss 
(2006) 
Social Challenge. 
Conducted in-home at 
approximately 3pm. Fixed 
order presentation of one 
15-20m session of each of 
the following conditions: 
child interview, silent 
Saliva (Salivette cotton 
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reading, oral reading, 
singing. 
Hall, Lightbody & Reiss 
(2008) 
In home assessment 
including intelligence and 
autism testing.  
Saliva (Salivette cotton 






dinner (5pm), and pre-
bedtime (9pm).  
- 
 
Roberts et al (2009) Naturalistic interactions 
with experimenter 
Saliva (Salivette cotton 
roll soaked 1-2 m). No 




assessment.Time of day 
not specified. 
FXS+ASD higher baseline and post-assessment 
than FXS-only. No group difference in magnitude 
of response.  
FXS+ASD higher post assessment and baseline 
than TD. No differences FXS-only and TD. No 
differences in magnitude of response. 
Scherr et al (2016) Neurocognitive assessment 
battery 
Saliva (Salivette, 1-2 m) Baseline 15m (pre-
assessment: 9am) and 
conclusion of 
assessment (12pm). 
Taken in Year 1, 2 and 3 
of longitudinal 
assessment 
Visual trend for increase in baseline cortisol over 
time (each year of longitudinal study). Not seen 
in TD. 
Both groups showed lower reactant cortisol than 
baseline. Year 1: FXS had significantly higher 
reactant than TD. Not significant at other time 
points. Non-significant trend for FXS to show 
greater change in time of cortisol (reactant-
baseline) than TD.  
Wisbeck et al (2000) 
 
 
Social Challenge modified 
from Herbert and ǯ
(1991). Two 2-minute 
interpersonal role-play 
tasks: speech/song and 
 Saliva (Salivette cotton 
roll soaked 1-2 m). No 
citrus <30m or dairy 
<60m 
 
Day 1: evaluation day. 
Pre-breakfast, 30m post-
stress, 90m post-stress, 
pre-dinner, bedtime.  
Days 2&3: routine days. 
Routine Days. Compared to normative, FXS 
higher at lunch and bedtime (no pre-dinner 
sample to compare) 
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reading aloud.  Pre-breakfast, pre-lunch, 
pre-dinner (no data for 
normative sample), 
bedtime. Average taken 
at each time-point 
across 2 days. 
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Gender comparisons of cortisol levels in individuals with Fragile X Syndrome 
 Study Participant Type N Aspect of HPA activity 
measured 
Gender comparison findings 
Hessl et al (2002) Human 39 (F), 70 (M)   Typical day circadian rhythm 
(average 2 days) 
Males and females both 
exhibited a normal diurnal 
decline. Males showed 
slower decline (higher 
cortisol) post-lunch until 
bedtime than females.  
   Experimental day circadian 
rhythm (involves novelty 
and social challenges) 
Males had greater response 
to visit than females: less 
decline (higher levels) 
between pre-breakfast and 
pre-lunch. Possibly related to 
meeting novel experimenter. 
Hessl, Glaser, Dyer-Friedman, & 
Reiss (2006) 
Human 32 (F) 58 (M)* 
 
Reaction to social challenge 
(pre and post measures) 
No gender differences in FXS 
participants.  
Hall, Lightbody & Reiss (2008) Human 29 (F) 31 (M) Collection at four time points 
during evaluation day 
No main effect of gender 
Wisbeck et al (2000) 
 
 
Human 7 (F) 8(M) 
 
Typical day Circadean 
rhythm (average 2 days) 
No male and female 
difference.  
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   Experimental day circadian 
rhythm (involves novelty 
and social challenges) 
Males significantly higher 
than females 30m post-
stressor and before bedtime. 
Markham et al (2006) Mouse 8-12 per group Response to acute stressor 
(restraint) 
Different patterns of 
response and recovery to 
30m of restraint stress. 
Males show protracted 
return to unstressed 
baseline; females show 
protracted rise. Peak 
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Studies assessing associations between cortisol and behaviour in individuals with Fragile X Syndrome 
Study Behavioural measure Association of behaviour with cortisol?  
Topic Method Typical Day Experimental Day Other 
Pre-challenge Reactivity Post-challenge 





















- - - Males. Composite 
cortisol level 
(unspecified) 
accounted for 8% of 












levels account for 
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social and attention 
problems.  

























both males and 










Aman et al, 
1985); CBCL and 
Autism Behaviour 
Checklist (Krug, 
Arick, & Almond, 
1993) 






in FXS (no other 
associations). No 
associations in 
sibling group.  
- - 
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challenge.   















- - - 









& Risi, 2002). 













& Parker, , 1995) 
 





- - - 
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